>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:1;Drug:ControlApo0.5M
bRobRjbLgbRobRcbRcbRcbRcbRebRibRobRobRcRssbLobRobRsbLobRob

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:2;Drug:ControlApo0.5M
bLcLssbRebLcbRiRsLssbRsRibLobLhbLcbLcRsbRcRssbLsbLebRgbLobLsb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:3;Drug:ControlApo0.5M
bLgbRgbLgbRibLibRsbLgbRsbRibRibRibRsbLibRgbRgbLgLsbLsLssbLsbLsbRiRgbRsbRsbRsbRsLsbRgbRibRgbLibLibRiLsbLgLsbLgbRcbRsbLsbRsbLebRgbLgb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:4;Drug:ControlApo0.5M
bLibLcbRibLhbRjbRiRssbRcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:5;Drug:ControlApo0.5M
bRibRsbLjLjbLibLgbLgbRibLgbLgbRsbLibLoLssbRiLsbLgbRgbLibLibLibRibLiLsbRibLjbLibLjbLibLibLjbRhbLsbLibRhbLibLibRibLsbRjbRjRssbLibRsRssbLgLsbRibRjbLjbRjbRobRjbRjbLjbLjLssbLsbRjbRjbLcbRcLsbLibLobRobRcbLhLsbRobRobRcbLcbRibLjRsbRobLcbLcbLsLssbRibRjbRcbLjbRobRobRjbRobRjbRcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:6;Drug:ControlApo0.5M
bRgRssbLcLssbLiLsbLibLsbRcbRcbLgbLeRsbLhbRsRssbRgbLebLgbRjbLibLsbLibLiRsbRsbLiLsbLsbLgbLgbLsbRsLsbLsbLiRsbRjbLjLssbLgLsbLsbRgbLgbRibRibRibRiLsbRsLcbLcbLobRjbRibRjbLgbRgbRsbRgbLcbLhbLjbRgbRibLibRibRobRibLgb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:7;Drug:CNO1microMApo0.5M
bRiRssbLibLsbLsbRsbReRssbRebRibRjbLhbLsbLibRcbLibLcbRcbRcbRcbRcbRhRssbRcbLebRobRebRebRobLibRibLobRibRibLjLssb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:8;Drug:CNO1microMApo0.5M
bLhLsbsbLjbLgbLjbLibLjbLhbRcRssbLiLsbRhbRibLjbRjbRcbRibRcLsbRjbRiLsb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:9;Drug:CNO1microMApo0.5M
bLcbLjbRcRssbRjbRobRobRcbRsbRsbRjbRcbRcbRjbRobRcbRobRobLibRjbRhbLobRjbLgbRcbRobRcbRjbLibLoRsbRcbRiLsbRjbRcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:10;Drug:CNO1microMApo0.5M
bLcbLibLgbLsbLgbLgbLgbLgLsbRoRssbRsbRgbRgLsbRgLsbLgbRgbLjLssbLibLsbRcbRcbRcbRibRsbRjbLgbLjbLcbLibLibLcbLjbLibLjbLhbLibLjbLjbLcbLhbLcbLgbLibLjbLcbLjRsbLibLibLjbLebRcbRhbLsbRsbRcbLibLibLjbLjbLcbRebLibLebRebLiLsbLiLsLssbRsbRsbRibLobLibLebReb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:11;Drug:CNO1microMApo0.5M
bLgLsbLgbLgbLgbRsLsbLgbLgbLgbLsbLgbLgbRsLibLibRgbLibLgLsRsbRgbRcLsbLiLsbRsbLsbRiLsbLgbRoRssbLibRibRibLsbLsbRibRibRgLsbLsbLsbRsbRgbLjLiRsbLgbRcbLjbLibLgLsLssbLsbLgLsLssbLsLssbLsbLgbLgbRobRibRgbRsbRjLsbLsbLibLgbRibLjbLiRsbLibRgRssbLgbRsbRobRibLgbRcbLsbRcLsbLsbLgLsbRobRiLsbLsRsbRgbRcbRibRibLgbRsRssbRsRsLsLsssbLsbLcbLsbRgRobRobRcbLsbLiLsbLibRobRjRssbLibLibRobLjbRcbRhbLibRhRssbLgbLhbLobLhbRibRibLgRsbRsbRcbRibRgbLsbRgLsbLjbRobRgbLgbLibLgLsRsbLgbLgbLgbRsbLsLssbLgbRebRgbRgbLsbRibRgbRgRssbRibRibLgbRsRssbRibRibRibRibRsbRcbLcbLhbLibLibRcbRcbLhbLibLsbRjbReLsbLibLgbRibRibLhbLcbRjLsbLcbLibLibRebLibLgbRgbLibLgbRgbLjbRcLsbRebLibRjbLibLjbRjbRebRobRobLibRibLgbLgbLcLssbLibLibLibLhbLhbLibLibLhbLobLibLcbLibLhbLhbLobLibLsLjbLibRhbLhbLobLibLjbRjbLcbLcbLjbLcbRgbLgbLjbLcLssbLibRgbRobRibLjbLibLjbRibLhbRsLibRgbLobLgbRgbLibLobLobLjbLcRsbLibRibRgb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:12;Drug:CNO1microMApo0.5M
bLobRgbRsbLobRcbLhbRjbRibLsLssbRibRgb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:13;Drug:CNO3microMApo0.5M
bRgbLjbLiRsbLibLibRibLjLssbRhbLhRsbLsbLgbRgbRjbRcbLoLsRssbLcbRibLoRsbLhbLebRcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:14;Drug:CNO3microMApo0.5M
bLgbLgbLgbRgRssbLibLibLsbLibLgbLsbLsbLgLsbLibLibLiRsbLsbLsbLgbLibLgbLgbLibLgbLsbRsbLgbLiLsbLgbLgbLibLsbRibLibRibRibLjbLibLjLssbLjLgbRibLibRsbLibRiRssbRjbLebRcbLebRhbLjbLsbLcbRhRssbRebRcbRcbRcbRcbRhbLcbLsbRcbLibRibLibRibLjbRhbRjbRcbRhbRjbRhbLjbRcbRjbRcRssbRibRobLsRsbRjbRcRssb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:15;Drug:CNO3microMApo0.5M
bRsRssbRgbLcbLibLsLssbRjbLobLsLssbLsbLgbLgbLgbLgbLgLsbLgLsbLgbLsbLsLsRssbLsbLsbLgbLsLsRssbLsbRsbLgbLsbLgbLsbRobLsLsLsssbLsLssbRsLsbLsbLiLsbRgLsbLgbLgbLsLssbLgbLhRsbLibLibRhbRhbLcRsbLcLssbLgLsbRibRjbLhbsbLibLiLsbRjbRcbRiLsbLjbLebLibLgbRgLsbLhbLcbRibRgbRjRssbLhbLjbLebRcbRhbRibRibLhbLcbLhLsbLcbRjbLobRcbRcbRhbRcbRhbRhLsbRibRhbRhbLibRobRibRjbRobRibRhbRibRgbLobsbLcbLcbLhbRhbRobRcbRibRobLhbRibRhbLcLssbLibRebRcbRjbRcbRhLsbRibRjLsbLcbLcLssbRcbRibLjbRcbRcbLhbLjbLhLsbRibRgbRjLsbRcLsbLibLjbLcbRgbRjRssbLjbLjbLcRsbLjbLcbRibLcbRjRibRibLcbLgRsbLgbRgbLgbRgbLsbLcbLgbRgbRjRjLsbRcLsbRhbRibRjLsbRibRibLjbRob

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:16;Drug:CNO3microMApo0.5M
bLsbReLsbRsRgbRgbLsRsbRibRcbRgbLibLgbRobRibRgbRgbRgbRhbRibLgbLgLsbRgLsbLgbLsbLgbRsbRsRhbRibRgbRibRgbRibRgbLgbRsRibRibRibRibRibRjbRcbRhbRsRssbRcbLsbLcbLcbLhbLhbLibRibLsbLjbRibRjbRcbRhbRibRgbLgbRsbRcbRgbLjbLibRcbRjLsbRjbRibRibRjbRjbRhbRibRjbRibRibLcbLcbLibLgbLgbRsbRibRiRssbRjbRibRibRgbRcbRibRcbRjbRhbRibLjRsbRcbRibRhLsRsLsbRcbRgbLibRcbLjbRobLobLibLjbLibRjbLebLhRsbRsRjbRjbLgbRibLgbLjbLgbLhRsbLgRsbLibLgbLsbRgbRjbRobRjbRobLgbRsRjbRobRhbLjbRobRibRobLgbRjLsbLjbLjbRobRsbLibRibRibLibLjbLibLcbLcRsbLhbRjbLcbLcbLcbRjbLcbRcbRgbLcbLsLhbRcbLebLcbRcbRjLsbLcbLcbLibLibLjbLcbLcbLhbLcbLcbLcbLcbsb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:17;Drug:CNO3microMApo0.5M
bLibLgbLebLcLssbRhbLsbLibLebRsbLgbLgbLcbLiLsbRgbRgbLgRsbLgbRgbLibLibRsbRsbLgbLsbRsbLhbRsbLiRsLsbRsbRsLgbLsbLgbLsbLsbLsbRsbLibLgbLsbLsbLibRsbRjbRibRgbLsLssbRibLsLssbLjbLibRibLsRgbRobRibRgbRsbRibLiLsbRgbRiLsbLhbRsbRcbRgbRcbRibLgbLjbRobLcbLgbLcbRgbLibLgbRgbLiLsbLgbLsLssbLgbRjbLcLssbRebRibRgbLibLjbRsbLiRsLsbLgLsbLsbLgbRsLsbLiLsLssbLgbLsbLiLsbLsbLgbRsbLgbLsbLgLsbLsbLiRsLsbRsbLibLsbLsbLibRjbRibRiRsRsssbLsbLjbRebLsbLibLgbRgbRobLcbLoRsbLibLcbLibLgbLibLibLibLgbLgbRjbRcbRhbLibRjbLibLhbRibLhbRhbRibLobLhbLibLibRibLcbRgbLcbLcbRsbRjbRibLcbLibRgRssbLobLhbLgbLhbRgbLibLgbLibLhbLgbRsLsbLgbRcbRebRibRsLsbLgbLgbRcbRobRgbLhbLhbLobLjLibLhbRibRgbLhbLebRjbRhRssbRibRcbLhbLibLibRgbRibRibLibLibLibLhbRjbLhbLibLibRgbLibLiLsbLgbRjbRcbLhbLcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:18;Drug:CNO3microMApo0.5M
bRsbLobLhbRgRssbRgbLsbRiRssbRibRcbLibRgRssbRobRibLgbRibRgbLeLsbLgLsLssbLgbLibRgRssbRsRsRsssbLibLgRsbRibLsbRjbRgbRiRssbLibLgbLsRsbLibRib

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:19;Drug:CNO10microMApo0.5M
bRsbsbRobLibLobLsbLiRsbLsbLobLcLssb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:20;Drug:CNO10microMApo0.5M
bRcLsbLgbLsbLibLgbLgbLsbLibLgbLsbRcbRgbLjbLhbLgbLibLibLgbLibRjRssbLjbLibLjbLjbLjbLjbLibLibLgbLjLibLjbLibLjbLjbLjbRibLjbLcbLcbLjbLjbRsbReRssbLhLsbLebRcbRjbLcbLjbLcbLebRjbRjbRcbRsbLsbRcbRibLhRsbLjbRcbRjbRcbRjbRcbLhRsbLcbLebLjbLjbLhbLcRsbLcbLcbLobLebLcbLcLssbLjbLhbLgbLsbLcbLgb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:21;Drug:CNO10microMApo0.5M
bLgLsbRgRssbLgLsLssbLsRsbLsRsbRsbRsbLgbLsbLebLobRhbRcRsLssbRib

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:22;Drug:CNO10microMApo0.5M
bRhbLibRibRibLcbLsLssbRibLhbLibLhbLgbLibLibLibLsbRsbLjbRjbRcbRiRssbRibRgbRgbRibRgbLsbLsbRgbRibLhbLibLsRsbLhbLcbLibLibRsRibLeLsbLjRsbLobLhLsbLcbLibRibLcbRcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:23;Drug:CNO10microMApo0.5M
bRgbLgRsbRibRgbRibRibRgbRgbRsbRsbRgbRibRibLgbRibRibRgbRibRgbRsbLsbRibRgLsbLgbRhbRhbRibRgbRgbRgbRgbRgbRgbRsbRsbLgbRibLibLobLgbLjbRibRiRssbRibRibRsbRgbRgbLsbRibLibLibLibRgRssbLsLgbRsLibRjbRibRgbRibRibRgbRibRhbLiLsbLgbRcbRiLsbLjbRcbLibRibLebLebLjbLcbLebLjbRcbLjbLobRcbRobRcbRjRssbRhbLcbLjLssbRibRjbRjbRobLsRibRhbRhbLcbRcbLjbRibLcbRebLibRcRssbLcLssbLcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:24;Drug:CNO10microMApo0.5M
bRgbLhbRsbLgbLsbLsbLsbLsbLgbLgLsbLsbLibLgbLgLsbLsbLsbLgbLiLsbLeLsbLgbLsLssbLgbLgbLibLsbRsLgbLsbsbsbsbsbsbLsRsbLgbLsbLsbLsbRjLsLebRsLsbLsLsRssbLgbLsbLsbLsRsbLgbLsbLibLgbLjb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:25;Drug:ControlApo0.5M
bRibLgbLsbRsbRcbRgbRibLibLibLcbLibLjbLibRcbRsbRcbRsbRobLgbRobRibRgRssbLgbLjbLgbRibRjLsbLgbLsbRobRhbRibRjbLibRcRssbLjbLcbRhbLibLcbLjbRgbLjbRgbLjbRgRssbRiLsbRsbRcbLgbRibRibLcbRjbRgbRjbRibRibRjbRebRobRjbLjbLcbRcbRebRobRcbRcbRcbRibRgbLjbReRssbRjbLhbLebLsbLgbRcbLjbLcbRcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:26;Drug:ControlApo0.5M
bRiRssbRibRgbRsbRcbLsRsbRibRibRiRssbRiRssbRsbRsLsbReRhbRibRjLsLssbRibLjLssbRcLsRsbRgbsbLibRhbLsb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:27;Drug:ControlApo0.5M
bLsbRibRsbRhbRibRgbRgLsbLsbRgbRibLjLssbRjbLibRjbRcbLebRcbLjbRobRhbRibLjbLgbRgbLgbRiLsbRsbLjLssbRibLjbRiRssbRhbRjbRhbRcbRjbRjbRcbRcbRjbRjbRgbRcbRibRcbRcbRcbRhbRjLsbRcbRjbRcRssbRjbRibRibRgLsRsbRgbLebRjbRgbLibRjbRcRcRssbLebLobRibLjbRcbRjbRhbRcbRibRiLsb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:28;Drug:ControlApo0.5M
bRibRiRsLssbRgbRgbRibRgbRiLsbRgbRgbRgbRgbLsbRgbRgbRgbRgbRgbLsbLsbLsbRibRsRssbRgbRsbRsLsbRsbRgbRgbRgbRgRssbLsRsbLsbRgbRiLsbRgbRsbRibRsbLsRsbLsbRibRgbRjbLiLsbReb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:29;Drug:ControlApo0.5M
bLgbLsbRgbLibLgbRsLsbLsbRsbRgbRgbLgbLgbLsbLsbLsbLsbLgbLsbLsbLsLssbLsbLsbLsbLsbLsbLgRsbLibRsbLsbLsbRsbLsbRsbRsbRsbLibLibLsbLgbLgbRsbRsbRsbLgbLgbLgbRsbLsbLgbLgbLgbRgbRcbRgbRsbLsbRsbRgbLsbRgbRgbRgbLgbRgbLgbLjbLgbLsbLgbRjbRjbLibRcbLcbRcbRcLsbRcbRcbRibRhbRcbsbLcRsb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:30;Drug:ControlApo0.5M
bRibLhbRgRsRsssbLgbLsb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:31;Drug:CNO1microMApo0.5M
bRibLgbLibRibLgbLsbLgbRsbRsbRcbLgLgLsLssbRhbLjbRhLsbRoRssbRgbRgbLibRibLebRjbRgbLib

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:32;Drug:CNO1microMApo0.5M
bRibRibRsbLsbLgbRcbRcbRibRgbLsbRsbRgbLibLiLsbLsbLgLsLssbLibLsbRebRgbRibRgbRgbRsbRgbRsbRsbRsbLcbLsbRibRgbLsbRgbRibRgbRibRsbRgLsbLsbLibLsbRjbRgbRjbRibRiLsbRgbRibRibLibRibLsbRibRgbRgbLsbRibRgbRiLsbLsbRjbRcbRcbRibRjbRcbRgbRjbLsbLsLgbRsbRibLsLssbRgbLgb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:33;Drug:CNO1microMApo0.5M
bRgbRgbRgbLibLcLibRgbRgbRsbLibLiRsbRgbLgLsbLsbLiRsbLsbLsbLsbRsbLgbLsLgLsbRsbLgLsbLibLgbRsbRibLcbLibLgbLibRibRgbLibLgbLgbRjbLibLibRjbLsRobRcbRibRibRgbRgbLgbRobRibRibRibLgbLsbLgbRibLgbRiRobRsbRgbLibRsbRgbLibLsbRjbLhbRibRibRjbRibRibRgbLhbLibRsbLsbLcbRibRsbLsbLibRsbRsbLgbLgbRsbLibRsbLibLibRsbRibLgbRgbRgbLgbRibLgbLibLgbRcbRebRhLsbRobRjbLibLcbRhbRcbRibRsbRjbLhbLibLcbRgLsbRsbRibRsbRgbLibLcbRibRibRjbLhbLsbRibRsbLsbRibRcbRibRgbLhbLjbLjbLsbLsbLibRgbRjbLibLsbRgbLoRsbRiLsbRibLcbLcbLibLjbRjbLcbRgbLcbLsbLgbRsbLjbRibLjbLcbRcbRibRgbRibRsbRgbLsbRjbRibRgbRjbRcbRebLibLjRsbLcbLcbLcbRibRgbRjbRobRibRjbLjbRsRgbLibLcbRibLjbLgbLcbRsbRobRcbRobRibRjbLebRsbRcLsbRsbRsbRsbRsbRsbLjbRibLcbLibLjbLjLsRssbRjbRsbRhbLobLcbsbLgbRibLjbLjbLgbRsbLcbLjbLhbLhbRibRsbLsbLgbLsbRebRgbLjbLobLhbRcbRobRobRibRjLsbLcbLjbRjbLjbLebRcbRcbRoLsbRgbLoRsbRobRhbRobRebRibLjLssbRobRjbRsbRibRgbRgbRgbLgbRebLibLsbRibLgbRjbLibRjbLhbRjbLobLcbRsbLebRibRobRjbLobLebLcbRjbLibLcbLebRibRibRgbRgbRsbLgbLgbLobRgbRsbRibRhbRobLjbLobRibLibRjbRhbLjbRcbRsbLibRcbRcbRhbRibRebLsbLibLcbLibLjbRcbRsbLcbLgbLcbRibRcbRcbLjbLobLjbLcbLibRibLibLcbLibRibLcbRjbRibLsbRibRibRjbRjbRjbRibRebLibRebRgbRibRgbRebLgbRibLibRjbLsLoRsbLcbLjbLcbLcbLhbLcbLcbRcbRibLcbLgbLobLcbLibRcbRjRssbRjb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:34;Drug:CNO1microMApo0.5M
bLibLiLsbLjLgbLjLgLsbRibLsbRcbLgbLibLibRsbLjLssb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:35;Drug:CNO1microMApo0.5M
bLcLssbRibRgLcbRcbLobRibReRssbLibRobLobRobRibRcbLhbRobLsbRsbRcbRhbLibLjLssbLibLiLsbLsbRsLsbLhRsbLcbLgb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:36;Drug:CNO1microMApo0.5M
bLgbRsbLsbLibRgbLibRjbLibRgbLgbLebLhbRibRsbLibRgbRgbLgbRgbRibLgbLibRibRgbLibRibLcbRibLsbLgbRsbLsbLibRgbRgb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:37;Drug:CNO3microMApo0.5M
bLgbLibRibRsbRsbRsbRsLsbRsbRgbRsbRsbLgbRgbRibLjbRgbRgbRgbRgbRsRsRsssbRsRssbRsbLsbRsbRhRssbRsbRgRssbRgRssbRgbRgbRsbRcRssbRhbRiLsbRsbRibRcbLjbRcLsbRgbRgbRsbLjbRibRibRibRcbLhRsLsbRgbLiLsbRebLiRsbLibLhbReb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:38;Drug:CNO3microMApo0.5M
bLgbLsbLobLibLcbLibLhbLibRjbLhbLcbLebLibLcbRjRsRsssbLiRsbLcbLcbRcLsbRcbLiLibRhbLib

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:39;Drug:CNO3microMApo0.5M
bRsbLibLgbLibLsbRgbLgbLibLibRgbLgbLiLsbRjRebRibLgbLsbLobLhbRibRobLebRsbLcbLiLsbLcbLibLhbLobLcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:40;Drug:CNO3microMApo0.5M
bLsbLgbLgbLsbLgbLgbLgbLsbLgRsbLsRsbLsRsbLgbLibLsbRsbRsbRsbLgbLgbLgbRsbLsbLgbRsbRebRiRssbLsbRgbLsbLsRsbLgbRibLsbLsbRgRssbRsbLsbRsbLjLibLgLgbLsLssbLsbLgbLsbRsbLgbLsRsbLsbLgbLsbLsbLjLssbRgbLsbLsbLibLsbRgbLsbLsbLibLgbLsbLsbLsbLsbLgbLibRsbRsRssbRgbRjRssbLibLsbRjbRcLsbLhbRebRibLgbRcbRibLsbLibRhbLibRcbRibLjbLsbRjbLcRsbLcbRhbRcbLhbRjbLibLcbLcbRibLsbRjbLjbLjbRibRsbRebLibLgbLsbLsbLcbRibRsbLcbLsbRibRcbLsbRjbLjbLsLssbLsbLsbLjbRibRsbRjbRsbLjbLsbRobRibLgbLebLjbLgbRcbRjbRjbLibRhbRgbRibLibLsbLoRsbLib

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:41;Drug:CNO3microMApo0.5M
bLhbRgbLgbRibLhbLsbLobLcbLhbLjbLcbRcbRibRcbLjLssbLobLcLssbLhbLobRibRsRcRssbLjbRsLcbRcRjbLebLobRgbLgbRcbRgLsLssbLcbRcbLgbRcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:42;Drug:CNO3microMApo0.5M
bLhbRsRebLhbRsb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:43;Drug:CNO10microMApo0.5M
bRgbRgbRgbRgbRiRssbRibRjRssbRsbRgbLibRsRsRsssbLgbRgLsbLgbRobLhbRiRssbRibRiRssbLgbRibRcRssbRibLobLjbLcLssbLsbRsb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:44;Drug:CNO10microMApo0.5M
bLibRhbRibRcbRibRibRibRgbRiLsbRiRssbRgbRibRibRgRssbRgbRgbRgbRgRssbLsbRibRgbRsbRgbRibRgbRgRssbLibRebLjbLcbLsbLhbLgbLjLssbLsbRhbLcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:45;Drug:CNO10microMApo0.5M
bsbLgbLibRiRsLssbLjbLsbRsbRsLsbLgLsbLgRsbLgbLgbLgbLibLgbLiRsbLsbLibLsbsbLibLgbRibLhbLibLibRsbRibLcbLgbLgbRgbLhRsbRibLhbLibRibRibLcbLjbLibLjRsbRgLsbRgbLjbLibRibLhbLibLhbRibLibLibLibLiLsbRsbLcRsbLjLssbLibLibRibLjLssbLhbLibLsbRgLsbRhbLhbLhbLhbRibRiLsbRibLhbLcbLibLibRibLibLibLcbRibRgbLcbLcbLibLibLgbRhbLcLssbLibLibLhbLhbRjbRcbRcLsbLibLhbLgbRgbRobRcbRibLjLjbLjRsbLibLibLjRsbLsbLjbRcRssbRcbRhbRjbRibRibRcLsbLhbRsRjbLibRcRssbRcbLjbLhbLgbLjbLibRhRssbLhbLhbLcbLhbRcbRgbLibRiRssbLibLgbLgbRiLsb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:46;Drug:CNO10microMApo0.5M
bLcbRcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:47;Drug:CNO10microMApo0.5M
bRsRssbLsRsLsbRsbRgbRsLsbRsbRsbRgbRsRsRsssbRsRssbRgbRsbRsRsLssbRsbRsbRgbRsbRsbLsbLcbLgbLgRsbRgbLsbLsbLibLgbLibLgbLsbLsbLsbRgbRibRobRsbRjbLibRgbLsbLgbLgbRibRsbLsbRgbRgbLsbLjbLjbRjbLjbRgbRjbRjbLcbRjLsbLjbRjbLjbRjLsbRjbRobRjbRhbRjbRjbLiLsbRcbRcb

>ZFRecording2016-03-21;tW:300s;Start:131724;End:132224;Recording:1-1;Individual:48;Drug:CNO10microMApo0.5M
bRsLsbLsLgbLgbLgbLgbRjbLgbLsbLiLcbLibLgbLgLsbLibLgbRgbLgLsbLgLsbLsbLgLsbLgbLgbsbRsbLsbLgbLgbLgbLobLsbLsbRibLsbLibLgbRsbLgLsbLgbLjbLibLibLibLgbLgbRhbRcbRhbLgbLgbLgbLsbLjLssbLgbLgbLibRibRjbRgLsbRgbLjbRobLjbRobRibLgbLgbLcbLibRgbLibRsLsbRgbLgbLsbRsbLgbRsbLsbLsbLgbRsbLgbLsbLgbRsbLgLsbRsbLgbRsbLgRsbRsbLgLsbLsbLsbLgbRsLgbRsbLibRgbLibLgbRibLibLibRsbLibLgbLgbLibRgbLibRgbRgbRjbRibLjbLjbLjbRjbLibRibRcbRcbRcbRibLibRgbLsbRjbRobRcbRibRhbRjbLjRsbRibLjbRibLibRjbRhLsbLhbLhbRjbRjbLjLssbRjLsbLcbRjbLjbRjbLibRibLhbLsbRgbLjbRjbRcLsbRobRcbRjbRibRjbRibLobRobLibRsbRgbLhLsbRibLjb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:1;Drug:ControlApo0.5M
bRjRcbLobLcbRibRsbLcbRcbsbRcbRcbRcbRcbLebsbRobRcbRcbRibRcbLcbRsbRcbRsb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:2;Drug:ControlApo0.5M
bLgbLsbLgbRjbLsbRibRgbLoLssbLsbRsRcbRobLcbRoRssbRcbRhbLcbRjRssbLjLcbRib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:3;Drug:ControlApo0.5M
bLgbLsLssbLgbLjbRibRsbRhRssbRebLjbRgbRsbLsbRsLcbLebLibLgbLibLgbRibLhbLibRebLgLsbRhb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:4;Drug:ControlApo0.5M
bRibRibRsLsbRib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:5;Drug:ControlApo0.5M
bRibRgbRobRobLcbRjbRcbLobRobRcbRobRjbLcbRcbLjbRsbRjbLcbLjbRcbRjbRobLcbRebRsbRibRiLsbRobLjbRcbRjbRgbRjbRcbRebRsLcbRoRssbRoLsbLsbRoLsbRebRhbRib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:6;Drug:ControlApo0.5M
bRcLsbLsRsbLcbRgbRgLsbRibRjbLoRsbLsbRgbRiRssbRgbRgLsbLgbRiLsbLibLibRgbLhbRcbLhLsbRcbRibLjbLjbRsbRgbRobLgbRibLsLssbLoRsbRgRssbRgbLebRjbLcbRiRssbLsbRgbLsbRsbLjbRjbLcbRhbLjbRcbLhbRgb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:7;Drug:CNO1microMApo0.5M
bRcbLiRsbRibLgbLobLsbLcbRibRgLsLssbLibLibRibLcbRhbLhbRibLjRsbRibLgbLsRjbLhbRcLsbLgbRibLibLibRobsbRcbLcbRjLsbLibLgbRcLsb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:8;Drug:CNO1microMApo0.5M
bRjbLsRcbLibLjbLjbRcbLcbLcbRjbRcbRibRibRgbLibRibRibLjb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:9;Drug:CNO1microMApo0.5M
bRcbRcbRibRebRcbRobRjbLhbRobRobLobRjbLibRsRcbLcbLcbLcbRjbLhbRob

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:10;Drug:CNO1microMApo0.5M
bLebRibsbLsbRsbLcbLibLebLgbRjRssbLcLssbLgbRcbRjbLibRebRsbLcbReRssb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:11;Drug:CNO1microMApo0.5M
bRibLibRgbRjbRcbRcbRhLsbLoRsbLjbLobLobLobRgbLcbLcLssbLibLgbLgbLsbLibLibRcRssbLcbLgbLcbLhbRsbLcbLcbLcbLhbLobLibLgbLgbRgbLobRjbRibRibRobRgbLhbLjbLibRcbLsbLibLjbRiLsbRibRjbLcbLobLobLcbLobRhbRibLcLssbLhbRgLsbLoLssbLibRibLsbLibLcbRcbLobLcbLibLibLgbLibRjbLeRsbLhbLjbLibLcbLobLcbLcbLibLsbLhbRobRebRobLjbRobLibLhLsbLcbRcbRibLhbRjbLobLjbLcbLibLcbRobLibLgbRsbLibLibLsbRobLibLcbLcbLjRsbLibLcbLcbRgbLhbLcbLhbRhbRjbRsbLobRjbRhbLsbLgbRjbRibLobLobRjbRcbRibLcbLjbLobLibLcbLjbLobLjRsb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:12;Drug:CNO1microMApo0.5M
bRjRssbLobRobRobLcbRgbLsLhbRibLibRibLsbRib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:13;Drug:CNO3microMApo0.5M
bLcRsbRcbLjbRcbRobRhbLiRsbRcbRhbLobLiRsbLsbLjbLobRjbRibRcbLibRcbLhb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:14;Drug:CNO3microMApo0.5M
bRjLsbRibRibRgLsbRjRssbRsRjbRjbRcbRjbRcbLhbReRssbRibRgLsbLjbRgbRebLsbLibRjbRsbLgbRibLgbLibLjLssbRsLsbRhbLgbRcbLcbLibLgbLsLsRsLssbLibLgbRhRgbLibLsbRcLsbLcbLibRhbRjbRcbRjbRebRsbLgbRcb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:15;Drug:CNO3microMApo0.5M
bRibRibRsbLjbLcbLcRsbLjLssbLcbRhbLoRsbLiRsbLcbLgbRhRssbRobRibRhbRibRgbRibRibLibRibLsRcLsbLcbLjbLcRsbLcbLibRcbRsbLibRgbLsbRgbLsbRjbLcbLjbLjbLibLhbLjbRjbRcbRjbRcbRjLsbRcbRgbRobLhbLibRhbRcbRhbRibRgbRjbRiLsbLsLsLsssbLgbRjbRhLsbRibLjbRcbRcbRgbLgbLgbLgbRjbRibRgbRgbRsLsbLeRsbLjbRjbRcbLjbLibRjRssbRcbLobLcRsbRjbLhbLjbLcLssbLjbRjbRcbRjbRjLsbRiRssbRsbLsbLgbLcRsbRjbLobLgbRjbRjLsbRcLsbRibLjbsbRgbRibLibLgbRgbLgbLgLsbRibLjbLibLgbLgbLgbLibLgLsbRibRsbLsbRgbRgLsbRibLibLibLsbRgbLcbLibLjbLibRjbLjbRjRssbLsbLsbRgLsbLsbLsbRjLsbRibLsbLsRsbLibLiRsbRobLjbLcbLcbLcbLibLjLssbRgbLgbLgbLsLssbRsLsbRgbRcbsbRjRssbRibRibLjbLibLcbRibRibRgbLsbLgbRjbRgbLsRibRsbRgLsbRsbRgbRgRssbRsbLsLssbRjbRibRibRsbRsbRgbLhLsbLobRiRssbRgbRgbRgbRsbRsRssbRgb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:16;Drug:CNO3microMApo0.5M
bRsLiLsbLsbRcbLcbLobLcbLhRsbLjLssbLcbLcRsbLhbLcbLibRiRssbLobLibLcRsbLibLgbLhb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:17;Drug:CNO3microMApo0.5M
bLibLsbLibLsbRgbsbRcbRibRgbRgLsbLgbLiRsbRjbLcbLgbLsbLhbLibRgbRibLibRgbLibLsbRibRsRhbRibLjLssbLhbLibLcbLibLgbLiLsLssbRsbRibRgLsbRobLgbRebLgbLgbRibLjbLcbLibRsbLibRebRhbRgbRibLibLgbLcbRiLsRsbLjbRhbRobRjbLsbLibRgbRgbLcbRibRebRjbRsLsbRgbLjbRebLcbLiLsbLcbLibLsbRgbLibLibLibLibRibLgLsbLsbLibLibRgbLibLsbRibRibRsbLibRcbLjbRsRibLhLsbLhbRobRcbLgbLcbLibRjbLhbLsbLsbRsbRgbLgbRcbRgbLcbLibLobRsbRibLhbRibRgbLsLjLssbLibLhbRcbRcRssbRibRgbLsbLjbLebRsbLcbRiRssbLgbLibLibRgbLsbLibLsbRjbLiLsbLhbLhbLebRibRjbRsbLobLibLib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:18;Drug:CNO3microMApo0.5M
bsbsbLgRsbRjbLjbRjbRsLoRsbRibRgbRiRssbRgbRibRgRssbRsbLgbRhRssbRsRgb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:19;Drug:CNO10microMApo0.5M
bRgbLobRibLoRsbRgLsbRibRobRiRssbRibLcbRgbLcbRcbLjbReLsbRibRjbLibRjbLiRsbLeRsRssbRcbRibLgbRgLsbLgLsbRobRsbRgbLebLibLgbLgbRsbRgbLgbRsbRsbRsbLsbLgbRsbLgbLjbRcbRcbRibRsbRjbLjbRjbLgbLgbLgbRgbLgb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:20;Drug:CNO10microMApo0.5M
bLcLssbLobLoRsbLcRsbsbLobLjbLjbLcbRsbLjbRibLobRebLcbRobLobLjbRsbRcbLibLoRsbLsLjb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:21;Drug:CNO10microMApo0.5M
bRibLibRibLjbLibRcbLjbRcbLcbRcbRiRssbLibRgbLhb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:22;Drug:CNO10microMApo0.5M
bRoLsbRobRcbLgbLcbRobLobRgbRjRgbLebRibRcbLebRhb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:23;Drug:CNO10microMApo0.5M
bLobLjbLobLcbLhbLebLobLjbRcbLjbRhbLcbLibLsLssbLhbLibReRssbLibLibReRssbLjLssbRjbLcbRjbRcRssbsbLebLgRsbLjbLoRsbLibLgLsbLibRhbRobRobRhbLsbsbLsbLobRjbRgRssbLhbLibRcbLjbLsbLgRsbRsLsbLgbLibLcbLebLhbLsRsbRcbRcbLjbLcbLibLib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:24;Drug:CNO10microMApo0.5M
bRcbLsRcbRgbRhLsbsbRcbLebRobLjbRsbRoRsRsssbLebRjbRibRoRgbRjbRebRsbRibRjbRhbRibRgbRob

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:25;Drug:ControlApo0.5M
bLcRsbRebRobRhRsRsssbRgbRibLibLcbRjLsbRibRib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:26;Drug:ControlApo0.5M
bRibLgbLgbLibLibLgbRjbRebRhRssbLoRsbLcbRsbRjbRcbRibLibLsbLjbRjbRjRssbRcbRibRhbRjbRibRgbLcbLcbRjRibLjbRibRjLsbLobRibRebRobRibRibLjbRibLobRjbRebsbRcbRhbRgbRibRebLibLgbRgbLgbLcbLjbRibRgbsbRjRhb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:27;Drug:ControlApo0.5M
bRjbRjbRcbRcbRibRgbRgbRhbLobRjbRibsbRobRgLsbRibRibLibRibLibRgbRibLsbLcbRcbRjbLobRibRibRibRcb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:28;Drug:ControlApo0.5M
bsbRibRjRgbLoLssbRiRssbRibLgb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:29;Drug:ControlApo0.5M
bRhbRcbRcbRibRgbRcbRcbRjLsLssbRiLsbRsb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:30;Drug:ControlApo0.5M
bLsLssbRjbLob

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:31;Drug:CNO1microMApo0.5M
bLibLibLebRgbLsbRoRssbLsLssbLgbRcLsbLobRjbLjbRjb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:32;Drug:CNO1microMApo0.5M
bsbRgbRibRgbLibRgbLibRjbRcbRsLsbRsbLjLssbRgLsbRgbRgbRgbLgbLgLsbLhbRgbRgbRsbRsRsRsssbRgbLgbLibLsb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:33;Drug:CNO1microMApo0.5M
bRjbRhbLibRibLcbRibLjbLobLhLsbLjbRjbRibLcbRjbRcbRibRhbRhbLcbRjbLjbRibLcbRibLcbLibLibRjbRjbRebRjbLcbLjRsbLibLjbRibRibRgbRjbRjbLibRsbLjbLjbRjbRjbRsRjbRjbRjbRjbRjLsbRibRjbLcbLobRcLsbRjRssbRcbRjbRcbLebRhbLcbLcbLcbLcbLcbLcbLebLcbLcb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:34;Drug:CNO1microMApo0.5M
bRgbsbsbsbsbRsbsbsbsbsb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:35;Drug:CNO1microMApo0.5M
bsbLgLgbLcbLsbLoLssbRoLsbLcbRobLjbLcbLcbRobLobRobLsLsLsRsssbRgbRsLsb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:36;Drug:CNO1microMApo0.5M
bRgbsbRsbRgbLibRgbLgbLsLibLgbLibRiRsRsssbLgbLsbLibLsbRibRgbRgbLgbLgbLgbLsbLcRsbLobRgRssbLobRgbLibRsbLsbLgbLgbLgbRsbRsbRsbLib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:37;Drug:CNO3microMApo0.5M
bLgbLibLibRebRebRebLobLsb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:38;Drug:CNO3microMApo0.5M
bRibLsbLgbLhbLhbRebLcbLhLsbLsLssbLibRjbRibLjbLcbLsbRhbRhLsbLibRcRssbLcbRsbRib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:39;Drug:CNO3microMApo0.5M
bLibLibLjbLcbLcbRjbLcbsbRibLebRobRib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:40;Drug:CNO3microMApo0.5M
bLhbLebLcbLjbLebLibLcbLcbLebLsbLibLcbLobRgbLobRibRhRssbRiRssbRgbLcbLsbLobRcbRsbLgbRjbLibLcbRcbRibRhbLsbRjbLjbRcbRgRssbRibLibRobRgbRgbLsbRsbRgbRsbLjbLibRgbRcbRjbRcbRibLsbLgbRibLgbRsbLsbLsbRibLgbLsRjbRhbRgbRcbRibLibLjbLibLgbLgbLsRsbRgbLgbLgbLgbRobRibLsLssbLcbRjbRjbRsRjbRsbRcbRjbRjbRsbLcbLcbRobRhbRjbRjbRjbRib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:41;Drug:CNO3microMApo0.5M
bLgbRibRobRoLsbRgLsbRibLobReRsLssbLebLsRobLgRsbRoRssbRsRssbRsRibReRssbLsb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:42;Drug:CNO3microMApo0.5M
bLibRobRcbLjbRibLcbLjbLcbLobRcb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:43;Drug:CNO10microMApo0.5M
bRsbLobRsbRgbRjbLsbRgbsbRcbLsbRhbRsbRsLsbRgbRgbLsRibRjbRcbRjbRiLsRsbLgRsb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:44;Drug:CNO10microMApo0.5M
bRgbRgbRobLib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:45;Drug:CNO10microMApo0.5M
bRiLsbLcbLibRibRibLibRgbRcbLcbLcbLcbLibLjbRcLsbLibRibLgbRgbRsLsbLibLibLhbLjbLoRcbLoRsbLibRibLibLibRcbLcbRgRssbLcbLjRsbRhbRibLiLsbLibRcbLgbLsbRibLgbLgbLiRsbRibLjRsbLibLibLsbLhbLgbLcbLibLhbRgbLebLibLhbLhbLibLibLibLsbLibLsbLgbLsbRcbLcbLcbLibRhLsbLibLibLgbLhRsbRcbLibLhbLiRsbLcbLhLsbLibLibLsbLgbRsbRgbLjLssbRcbLibLibLibLgbLgbLgbLsLssbLcRsRssbLjbLhLsbLjLssbLib

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:46;Drug:CNO10microMApo0.5M
bLgbRiLsbRjbLjLsLsssbLgLsLssb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:47;Drug:CNO10microMApo0.5M
bsbLsbRjbRobRgbRgbRjbRgbRgbRjRssb

>ZFRecording2016-03-21;tW:300s;Start:132226;End:132726;Recording:2-1;Individual:48;Drug:CNO10microMApo0.5M
bLgbRibRibRibRcbRcbRiLsbRgbRsbLjRsbRibLjbRibLsbRjbRhbRcbRcbRgRssbRibLibRibLjbRjbRhbRcbRhbRcbRibRsbRsbLsbRjbRjbRjbRhbRibRibRgbLhbRcbRgbLobLgbRjRsLssb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:1;Drug:ControlApo0.5M
bRibLjbRobRhbRibRcbRsbRibLobRcLsbLobRibRsbRcRssbRjRjLsbRcLsLssbRibRcbRcb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:2;Drug:ControlApo0.5M
bLgbReRssbRjbLcbRgbRsbLcbLcbLibLcbRibLjb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:3;Drug:ControlApo0.5M
bLgbLoLssbLcbLsbLsbLgbLiLsbRibLibRibRjbLebLsLjbLib

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:4;Drug:ControlApo0.5M
bRgRssbRibRgbRoRssbRibRgRibRgbRsbRgbRhbRibRibRcbRobRgLsbRcbRgbLsRibLsbRibRgbLibRobRibsbRgb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:5;Drug:ControlApo0.5M
bRcbRjbRjbRcLsbRobRcbRcbRsbRcRssbRcbRjbLcbRobRcRssbRsbRgbRsRcbRoRgbRiRibRoLsLssbLcRsbRcbRjbRcbLjbLsRsRssbLcbLoLssbRob

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:6;Drug:ControlApo0.5M
bRgRssbLgbRsbRsLsbRsbLobRhbLoRsbRobRgbRgbLobLsbRobLsbLjbLsbLsRsbRsbLsbLsbLsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:7;Drug:CNO1microMApo0.5M
bLsbLgbLgRsbLibRebLibRcbLjbRsbLibRebLsbRcLsbRcRssbRcbRobLibLiRsbRhbLjbLiLsbRhLsbLobRcbRiRsLssbRhbLjbRobRcbRcbRcbsbRgLsbRcRssb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:8;Drug:CNO1microMApo0.5M
bLjbRiRssbLibRgRssbLgbRibLibLjbRibRjRssbLcbLgbsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:9;Drug:CNO1microMApo0.5M
bLobRjbRobsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:10;Drug:CNO1microMApo0.5M
bLobRgbRgbLsbRsbRsbLsbRsbRsRsLsRssbRsbsbRsbRgbRibRebLgbRobRobRobRobLjbRobLobRobLjbLsbLebLjbRibRgbRibRsbRsLjbRobRibLhbRcbRobRoLsbLeLsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:11;Drug:CNO1microMApo0.5M
bRsbLjbLjbLhbRobRcbRhbLcbLibLjbRibLgRsbLcbLobLhbRibLibRjbLiLsbLhbLcbLcbLibLibLcbRsbRobRibLhbLibLjbRobRcLsbRhbRhbLsbLcRsbLcbLhbLebLibLhbLhbRobRhLsbLsbRjbRgbRjLsbLiRsbRibLcbRsbLsbRoLsbRsbLsRsbRcbLobRcbLcbLoLssbLibLoLssbLcbLcbRibRgbLobLjbLsLcbLibLobLcLssbLibLgbLjLsLsssbLhbRcbRiLsLssbLjbRoLsRobLobRcbRcbLhbLgbLjbLobLoLssbRcbLibRsbLcLssbLjb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:12;Drug:CNO1microMApo0.5M
bLgbRobRgbRibRgbLsbRjbLcbRibRiRssbRjb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:13;Drug:CNO3microMApo0.5M
bRjbLjbRob

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:14;Drug:CNO3microMApo0.5M
bLjbLebLjLsLsssbLibRibRgbLjbRoLsbLcbLcbLjbLoLssbLibLibRcRssbLibLsbLcbLobLgbLebLgRsbRcbRcbRcbLibRibRjbLjbLibRibRibLjbRcRssbRebsbLebLiRsbRjbLibRebLcbLiRsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:15;Drug:CNO3microMApo0.5M
bRsbRibRgbLjbLibLiLsRsLsbLsbRjbRjbRibRiLsbLibLgbRgRssbRsbLsbRgbRibRsbRgbRibLhbRibRgbRgbRgbRgbRsbLsbRgbLjbRjbLcLssbRjbRjbRibRjbRibLibRiLsbLgbLsbRsbRjRoLsbLsLjbLibLjbRibLibLibLibRsbLibLsbRhbRhbRhbRjbLcbLibRibRsbRsbRsbRgbRgbLsbRibRgbRgbRcLsbLcbLcbRibRjbRobRibRiRssbRhbRibLsbRgbRibRjbRjbRibRgbRsbRsbRgbRgbRibRsLsbRibLjbLcbLjbRjbRibRjbLjbLhbLcbLgbRsLsbLsbLsbLibRjbRhbRjbLhbLcbLibRgbLsbRsbLjbLsLibLibLsbLgbLsbLibLgbLsbLiRsbLjLssbLjRsbLcbLcbLibRgbLcbLjLssbLibLsbRiRssbRgbRsbLjLibLibLsbLiRsbsbLibLjRsbLibRjbLcbRgbRgbLsbLgbLgbLiLsbLcbRibRcbRibLibLgbLsbLgbRgbLjRsLsbLjRsRsRsLsssbLgbLgbLjbLjb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:16;Drug:CNO3microMApo0.5M
bRcbLcbLcbRcbLibLibLcbLcbLcLssbLcbLobLebLhbLhbRcbRobRobRjbRcbLcLssbRhbLcbLibRcbRcbRcbLebRcbRcbRcRssbRgbRcbLcLssbRcbRhbRcbRcbRibRibRsbLsRsbRgbRcbRibLcb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:17;Drug:CNO3microMApo0.5M
bRobRcbLibLhbLhbLsbRjbRcbLjbLsbLibRjRgbRibLibLiRsbRcbRibLjbRcbRsbLiLsbRgbRsLsbLsbLcbLibRibRsbRjbLcbLhLsbLibLgbLgLgbLsLssbRsbLgbLjbLibRgbLgbLhbRgbRgbLsbRibRiRssbRobRibLibRhbRgbLcbLgbRcbRcbRhbRgRebLcRsbLsbRiRsLssbLsbRsbLsbLcbLcbRgbLsbLhbLibRjbLiRsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:18;Drug:CNO3microMApo0.5M
bLibsbLibLgbRsbRgbRgbLgbRibLgbRgbRjbRibRobLgbLsbLgbLcLssbLibLjbRjbLibRhbLibLibRgbLibRgbRgbLibLobLcbRibLgbLsLssbRibRibRib

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:19;Drug:CNO10microMApo0.5M
bRjbRjRssbRjRssbRjbRcbRgbLcbRibLgbLsbRsbRsRibRsLsbRsbLgbRjbRsbRibRjbLjbLsbRcbRgbRcbRibRgbLgbLsbLsbRsbRibRgbLgbLsbLsbRibRhbLibRibLiLsbRibLgbLsbLgRsbRgRssbLjbLebRibLsbRsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:20;Drug:CNO10microMApo0.5M
bLcbLgLsbLsLjbLobRobLobLcbRobRjbLobLobLjbLcbRebLoLsRssbLjLoRsbLoLssbLebLoLssbLobRoLsbRobLsbRobLsbRcbRhbRibRhbRcbRcbRjbRibLcbRjbRoLsbLibRjbRcRssb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:21;Drug:CNO10microMApo0.5M
bsbRjRjRssbRhLsbsbsbRjRhbLoRgbRcb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:22;Drug:CNO10microMApo0.5M
bRcbRobRjRssbRibRhbLibLcbRgbLibLcLssbLsbRhbRibLibRibLsbLibRgLsbRib

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:23;Drug:CNO10microMApo0.5M
bLsLhbRsRiRssbLjbLibLjbLcbLcLssbRhbRjbLhRsbLsbRcbLjbLjLgbRjbLhbRibLcbLibLhbLhbLebLjbLjbLebLibLjLssbLsbRibLibLsLjbLibRjbRcLsbLibLibRcbRsLsbLibLgbLcbRjRhbLebLgbLjbLcbLib

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:24;Drug:CNO10microMApo0.5M
bRsbsbRobRibRibRcRssbLjbLjbLibRcbLebRcbLibRsbRebLebLiLsbLsLssbRgbRiLsbLsbLsRsbsbRcbLsbRsbReLibRibLsLgRsbRgbLibRib

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:25;Drug:ControlApo0.5M
bRibRgRssbRjLsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:26;Drug:ControlApo0.5M
bRgbRsbRgRiLsbRjRssbLjbLcb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:27;Drug:ControlApo0.5M
bRcbRjbRjbLobRjbRgbRgbLjLssbRsbRgbRgbRgbRjbLcbLobRjLsbRcbRjbRjbLobRibRibLgb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:28;Drug:ControlApo0.5M
bRjbLsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:29;Drug:ControlApo0.5M
bRjbRcLsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:30;Drug:ControlApo0.5M
bRsbLsbRsbRsbLsLssbRobRsbRgbRsbRgbLsbLebRsbRsbLsbLsRsbLsbRsbRsLsbLsLssbRsbRsbRsLsLssbLsbRsbLsbRsLsbRsRssbLsbRsLsbRsbRebRsLsRsLsbLsbRsLsLssbRsbRsLsRsLsbRsbRsLsbLsbRsbRsbRobLsbRsLsRsbLsbRsbRsbRsbRsbLsbRsbLsbRsbRsbLsbRsbRsbLsbLsLssbRobLsLssbLsbRsbRsRsLsLsssbRsbLsbLsbLsRsRebLsbLsRsbLsbLsbLsbRsRssbLsbLsbRsbRsbRsbRsbRsbLjbRgbLsbRsbLsbRsbRobRsbLsbLsbRsbLsbRsbRsRobLsbLsbRobLsbRsLsbRoLsbRsbLsbRobLsbLsbLsbLsbLsbLobRsbRgbRgbLsbRsbLsbLsbLsbRobLebLsbRgbRgbLsRgbRsbRsbRsbLsbRsbRsbRsbLsbLgbRsbRsbRsbRsbLsbRsbRjbRsbRsbRsLsbRsbLsbLsbRobRsbRgbLsbLebLsbLsbLsbRsbLgbLsbRsbLsbRsbLsbLsbRsbRsbRsbRsbLsbRsbLgbRsbLsbRsbLsbRgbLsbRsbRsbRgbRsbRsbRsRssbLgbLsbLsbLsbLsbLsbLsbLsbRsbRsbLsbRsbRsbRsbRsbRsbRgbLsbLsbLsbLgbLsbLsbRsbLobLsbRgbRsbLsRsbLsbRsbLsbRsbRgbLsbLsbRgbRsbLsbRsbLsbRsbRsbRsRssbRjbLgbRsbLsbLsbLgbRsbRsbRsbLsbRsbLsbRsLsbRsbRebRobRebRebLobRobLsbRsbLobLsbLcbLsbLsbLsbRsbLebRebRsbLobRebRoRebLobLobRobRjbLobRgbRsbRobLobLsbRobLsbLcbLsbRhLsbRebLgbRsbRobRsbLsbLsRebLsbLobRsbLobLjbLobLeLsbRsbRobLobRobRsbRcbRobRsbRsbLoRsbRcbRcbLsbLobRobLobRcbRsbRsbRsbRebRsbLobLobLsbLsbLcbLsbLsbRobLobRebLsbRebRsbLsbLsbLjbRobLebRobLjbRobRebLebRobRobLsbLjbLsbRsbRsbLsbRobRsbLsbLsbLsbRobRobLobRebLsbRsbRobRobLobLebLobLgbLsbRebRsbLobRoRebLsbRsbLjbLcbRsbRsbRsbRebLsRsbLobRebRobRebRobLebRobRsbLsbRsbLsbLgbRsLsbLobRebLebRsLsbLsbLobRsbLsbRsbRsbLgbLsbLebRsbLobRsbRobRsbRibRgbLobRsbLsbRsbLebLsbLgbLobLjbRsbLjbLsbRsbLsbRsbRsbLsbLsbLsbLebRgbRobRsbRsbLsbLjbLsbRsbRebLebRsbRebLsbRsbRsbRsbLsRebRebRebLsbRsbRebLsbLgbRjbRsbLsbRsbRjb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:31;Drug:CNO1microMApo0.5M
bRsbLebRobLsRsLsbLebRsbRebRebLebLgbLebRibRobRgbLebLebLobLgbRgbRsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:32;Drug:CNO1microMApo0.5M
bLgbRgbRgbLibLsbsbLsbLibLsbLsbLjRsbRsbLsbLgbRsbRobLcbRgbRgbRgLsbRgLsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:33;Drug:CNO1microMApo0.5M
bLcLssbRjbLcRsbLcbLcbLcbLibLcb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:34;Drug:CNO1microMApo0.5M
bLobRcbRobLobRobRobLebRobRibLibLcbRobRcbLsbRcbLcbLobLcbRcbRcbLgbLcbRebRobLobRcbRobLobRebRobRobRobLobLcbLobRobLobRebLobLibRobRsbLibLhbRobLobLcbRobLobLobRobRobLobLobRobLebLobRebRcbRjbLebLobRobRcbLebLobLebLebRobLebRgbRebLhbLgbRcbLibLebLebRgbLobLobRhbRebRhbLobLobLebLcbRebLebRebLgbRebRcbRsbLobRibRobLcbLebRobLebRcbRebLebLebRgbRobRibRobLcbLobRcbLebRibRcbLebRebRcbRcbRcbLibLsbLobLgbRsbRcbLgbLibRibLgbLobLibRebRobRobRobLsbLobLcbRobRibRobLebRobRebLobLibLebRobRobRgbLobRobRcbLobLobRobRebRebRebRobRcbLobLobRobLebLcbLibLibRcbLcbRobRobRobRobLobLobRgbLgbRobLobLobRobRobRibRobRebLcbRibLobLobLcbLobLebRgbRsbLebRobRhbLgbRebLebRebLobLebRgbLhbRibLobLobLcbLebRobLobLhbRebRgbRobRebRsbLebLebLgbRobLobLebRhbRobLgbRhbRgbRhbRcbLebRobLobRgbRobLobRebRibRcbLcbLobLgbLebLebRebRcbRcbLobRobRhbLcbRobRebRobLcbLcbRobRsbRebRobLjbLobLebRobRebRebRibLcbLobRobRsbRobRobRjbLobRebRcbRsbLobRcbRobLobLobLobRebLebLcbLobRobRcbLobLebRcbLibLobRobLcbRobLcbLebLobRobRobLcbRebRobLebRebRibLebLcbRobLsbLobRgbRebRcbRibRobRobLcbLebRgbLobRcbLebLcbRcbRcbRgbLebRebLobLsbRobRobRcbRobLobLebRebLobLobLebRebRebLebLobRobLobRobRcbLobLobRebLcbLcbRcbLcbLhbRobLebLsbLobLobLobLobLobRobLebLgbLobLibLobRobLgbRebLobRebLebRsbRobLcbRcbLibLcbLcbRcbRebRobRebRobRobRebRgbRobRobRgbRebRebLhbLebLebRobLgbLgbRsbLebRobRcbLobRebRobLcbLcbRebLobRobLhbRebRobRibRobRebLobRebRobRsbRebLcbLobLobLcbRobLgbLcbLobLobLobLobLebRhbRhbLobRobLobLobRgbRobLobRibRebRsbLebLobLebRcbRebRcbLgbRcbRobLobLibLebRcbLobRebRebLibRobRgbRobRcbLgbRobLobRcbLebRobRobRobRebRibRobRobLobLgbLebRobLsbRebLobRhbLhbRsbLibLobLobLhbRcbRebLcbRobLobRibRobLibRobRobRebRcbRgbLebRobRobRobLcbRcbRobLobLobRhbRebRibRibRcbRebRobRcbLebRebLcbRobLobLsbRebLobLsbLcbLibLhbLobRobLobRobLobRcbLebRebLgbLibRebRobRebLhbRibRobLobLebRobRgbLobRobLobRobLobLcbRobLobLibLgbLcbLcbLobLcbLcbRebRgbLobRobRcbRobLsbLebRebRobRobRobLgbRebRgbLcbLobRebLsbRcbLebLcbLcbLobRobRobRcbRobLobLibLibLibRebRebRebRobLhbLobLhbRcbRibLcbRibRebLobLcbRcbRibRobLsbRebRobLebLgbRobRcbRobLobRobLcbRibRobRebLobRobRobRcbRobRebLhbLgbLgbLcbLebRobLobLsbRebRebRebRibRobLjbLgbLobRgbLobRebRobRobRobRcbRcbRgbRgbLobLibRobRobLcbRjbRobLebLobRebRobLobLobRobLebRgbRjbLebRcbRcbLobLcbRebLobLobRibLebRibLibLobRsbRobLobLobRebLobRobRobLgbLgbLcbLebLobRobRhbLobLebLobRcbRobLobRibRebRibLgbLobRobLebLebLcbLebLobLcbLobLgbRcbLobRcbRobRcbLobLebRgbRobLibRcbLcbRhbLebLobLgbLgbLobRobLgbLobLsbLobLhbLebLebRsbRobLibRobLebRebLcbRjbLobRsbRobRobLsbRebRibRobRgbRobLobRgbLcbRibLebRobRobLcbLgbRebRobRobLebRgbRobRobRhbRobLgbRobRobRebRobLobRobRibRobLgbLobLebLebRobLobLobRobRobLebRobLobLobLcbRsbLobRebRobRobLobLobLobLsbRcbRebLhbLebLcbRebLgbRobLobLobRcbLobLibLebLebRhbLobRobRebLobRebLcbRobLcbRobRobRjbLobLebRibRobLobLcbRibRobLhbRobLebRcbLhbRebLibLebLcbRebLobRhbRebLobLibRobLobLibRobLibRobLobLobLobRcbRobLcbRcbLobLebLobLgbLjbLobLebRebLibRcbLobLgbRcbRobRebLsbLebLobRobRebRcbRgbRgbRobLobRobRgbRobLcbLobLobRebRobLgbRcbRebLcbRobLgbRobRgbRebRobLobLgbLobLebLobRibLebRobRobRobRebLcbRobLebLcbRcbLibRobRobLgbRobRebLobRcbRcbLgb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:35;Drug:CNO1microMApo0.5M
bRsbRebLsbRobRgbLebLsLgbLgbsbLsbLsbRcbRcbLobLobRsbRsbRib

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:36;Drug:CNO1microMApo0.5M
bLgbRsRssbLsbRsbRgbRgbLgbLhbLcbLcbLsbLiRsLsbRsRssbRjbLhbLsbLsbLibRsbRsbRsbLgLsbLibRsbLibLgbLsLssbRibLibRgbLibLsbLibRgbRgLsbLhbRibRsbLiLsbRgbLib

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:37;Drug:CNO3microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:38;Drug:CNO3microMApo0.5M
bLsbRgbLeLsbLsbLcbRjbLebLcbLsRsbLgbLibLibLsLssbLsbLcbLebRjLsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:39;Drug:CNO3microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:40;Drug:CNO3microMApo0.5M
bRcbRobRhbRcbRjbRebRcbRcLsbRcbRjbRcbRhbRibRjbRibRebRcbRsRssbRsRib

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:41;Drug:CNO3microMApo0.5M
bRcbRibLsbLjbsbsbRgbLcbLgbLib

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:42;Drug:CNO3microMApo0.5M
bLibLcbRsRibRobRsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:43;Drug:CNO10microMApo0.5M
bRgbRgLsbRibRibRib

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:44;Drug:CNO10microMApo0.5M
bLjRsbRibLgbLcbLibRsRssbLgbRgbRsbLibLibLebRjbRcLsLssbRibLibRsbsbLhRsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:45;Drug:CNO10microMApo0.5M
bLibLjLssbLjbLibLjbLibLgbLcbLsbLcbLjRsbRcbLgbLgbRiLsbLsbLgbLibRgbRiLsbRiRssbLjbLhbLcbLibLsRsbLhbLibLibLhbLgbLcbLibLibLsbRgbLibLsbLibRobLcbRiLsbLoRsRssbLibLcbLibLsbLhbLhbLcbLjLssbLgbRibLibLgbLibRsbRgbLgLsbRobRibRcbLcbLibLibLcbRhRssbLibLgbRcRssbLcbLhbRibLibLsbLsbLgbLgbLibLjbLcbRcbLibRibLhbLcbLjLsLsssbLibLgbLibLsbLgbRsbLgb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:46;Drug:CNO10microMApo0.5M
bLobLobLsLibLgLsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:47;Drug:CNO10microMApo0.5M
bLjbRhbRobRibsbsb

>ZFRecording2016-03-21;tW:300s;Start:132728;End:133228;Recording:3-1;Individual:48;Drug:CNO10microMApo0.5M
bRjbRibRsbRibsbsbRjLsbRjbRibRgbRibRebsbRjbRjbRibRibRibRhbRcbRjbRibRibRjbLcbLcbRgLsbRsbRgbLsbRibRhbRibLcbRibRsbRjbLgbRgb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:1;Drug:ControlApo0.5M
bRsRjbLobRgbRgbRsbLsbRsbLsRsLsbRcbRibRjbsbRsRjb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:2;Drug:ControlApo0.5M
bsbRcbLibRsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:3;Drug:ControlApo0.5M
bsbRsbRebLhbRibLgbsbRgbLiLsbLibRgbLgLgb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:4;Drug:ControlApo0.5M
bRhbRobLibLgbRcbRibLibLobRgbRhbRobLhLsbRsRssbLgbRcbRcbLobLcRsRgbLjbRhbRsRssbRibRsRssbLsbLsbLsLssbRjbLibLob

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:5;Drug:ControlApo0.5M
bRibRcbRhbRoLsLssbRcbRcLsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:6;Drug:ControlApo0.5M
bRsRssbRebLsLssbRsLsbLobLgRsbLgbLsbLobRgbRobRsbRcbLsbLsbRebRsbRcbRcbLcbReRsLssb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:7;Drug:CNO1microMApo0.5M
bLgbRiLsbRebLhRsbRcbRcbRcRssbRobRebLcbLcbLobLobLoRsLsbLgbRobRebRsbRgLsbRiRssb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:8;Drug:CNO1microMApo0.5M
bRjRsRsssbRibLsbRobRiLsbRibRcbRgbLibRcbRhbRibRibLibRgbRiRssbLjbLibLgbLhbLcbRibRibRgbRgbLibRibLcbLjbRjRssbLjbLsbLcbRsbLgbRsbLgLsbLibRibLgbLibLibLgbRjbLibRhbRsbRhb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:9;Drug:CNO1microMApo0.5M
bRoLsbRhLsbRgbRobLcbRcRssbRcbRobLgbRibLobLebRebLhbRcbLibRibLgbRsbRsRsRsssbRgbRjbLibRgbRibLcLssbLobLoRsbRjbLcbRjRssbRjbRobLibLjbLcbRcbLcbRobLibLibRibRsbLsbLgbLibLiLsbRjbLoRsbRcRssb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:10;Drug:CNO1microMApo0.5M
bLsRsbLibRcbLjbLcbRjbRsRebRibLiRsbRcbLcLssbLibRsbRsbLsbLjbLhbLobRhbLcbRcbRcbLobRcbLeLsbLhbRcRssb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:11;Drug:CNO1microMApo0.5M
bLibLgbLgbLibRgbRgbLhbLjbLoRsbRcbRibRgbRhbRgbLibRjbRcbRibLobLiLsbLibLibLibLcbLibLsbLgbLibRcbLsbLibLsbRcbRgb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:12;Drug:CNO1microMApo0.5M
bLibLjbRcbLsbRgb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:13;Drug:CNO3microMApo0.5M
bLjbRhbRsLsRsbRebRobLcbRcbRjb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:14;Drug:CNO3microMApo0.5M
bLcbRgbLebLjbRibRsbLcbRobRsbLcbLeLiRsbLjbLibRiRssbRgbLcLssbLibRjbRoRobLhbLiRsbLiRsbLibRibRsbLibRhbRgbRcbRcbRsRssbRebRcLsbLjRsbLibLgbRibRgbLcRsbLjRsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:15;Drug:CNO3microMApo0.5M
bLcbLhbLgbLcbRjbRoLsLsLsssbLgbRcbRibLeLsbLibLsbLcbRhbRcbLsbLsbRibLsbLjbLiRsbLcbLjbLcLssbLibRcbLjbLhbLiLsbLcbLcbRcLsbLjbLjbLhbLcbLibLgbRjbRebRhbLhbLhbRibLjbRhbLcbRcbRibRjbRcbRhbRibRgbLgbRsbLgbLgbRibLibLibLsbLjbLibLibRibRgbRsRssbLsbRgbLsbLibRjbLibRjbRgLsbLibLgbLjLssbLjbRibsbLibLjbLjLssbRibLgLsbLiLsbLsbLjLgLsbLjRsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:16;Drug:CNO3microMApo0.5M
bRhbRcbLsbLcbLhbRhbRibRoRssbRcbLhbRgbRobRgbRcbRibsbRgbRsbRobLsbRcbRsbRhbRgbRsbRibRgbLsbRobLsbLsbRibLgbLsbRsbLgbLjLssbLgbRobRgbRsLsbRgbRgbRoLsbLcbLcbLcbLgbLsRsbRcbRcbRibRiRssbRsbLsbRibRibRsbRgbLsbLsbRgbRgLsbRgLsbLsbRibRgRssbRgbLsbRgbLsbRsbRsRssbRgbRgbRgbRgbRgbLsbRsbRgbRgbRibRsRssbRsbRgbLjbLsbLsRsbRcbRsbRibRibLsbLsbLgbRsbRcbRcbRibLiLsbLcbLcbLibLgbLsbLsbRsbRibRgbLcLssbLibRjbRcbRcbRcbRiLsbRibRibRjbLcbLjbLibLibLcbRobRcbRsRssbRibRibLgbLgbRsbLsbRgbLgbRibRibLsbRibRgbRsbRsRibRcbRgbRgbRsbRgbRibLsbRgbLcbLhbRjbRobLjbLhbRjbRibRcbRibRsbRsbRibRgbRgbLebLhbLibLgbRsLsbRsbRgbRobLibLgbLgbLsbLgbRjbRibRiRssbLcbLgbRjbLgbLgLsLssbLgbLgbLsbLsLssbLgLsbLsLssbLgbLsLssbLgbLgbLsbRsLsLssbRsbLibRjbRjbRibRcbRibRgbRsLsbRgbRgbLsbLhbLcbLcbLjLssbLibLsbLsbRjbRobRgbRibRibRsbRgbLsbLsbLsbLsbLgbLgbLjRsbLgbRgbRhbRiRssbRsbRobRcb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:17;Drug:CNO3microMApo0.5M
bLibLcbLibLibLsLssbLibLibLibLjbRobLibLibLgbLsbRjbRibRebLgLsbLoRsbLibLgbLhLsbLibLhbRgbLjbLibLhbLsbRgbRjbRhbRibLgLsbLgbLgbLobLibsbLjbRobRobRcRssbLsbRgbLjbRsLgRsbLgbLcbLcbLjbLjbLjbLibLcbLiRsbRgbLibLgbLsbRibRgbRsbLibRibRsbRsbLjbLibLcbLebRsbLgbLsbLgbLgbLsbLibLsbLgLsbRibLsbLgbRgbLibRsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:18;Drug:CNO3microMApo0.5M
bRgbRgbRhbLibLgbRiRssbRibRjRsRsssbLsLssbRibsbRiLsbLibRibLibRsbRsbLjbRibRgLsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:19;Drug:CNO10microMApo0.5M
bLjbRjbLibRjRsRsssbRibLibRjbRibRibLsbLsRsbRgbLsbRcbRsbRibsbRsbLgbRjbRsbRcbRgb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:20;Drug:CNO10microMApo0.5M
bLgLsbLibRhLsbLcRsbLibRsLsbRgbLibLcbLgbLcLcbLcbLibLob

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:21;Drug:CNO10microMApo0.5M
bLcRsbRibRib

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:22;Drug:CNO10microMApo0.5M
bLjLgRsbRhbLcbRjbLcbLcbRebRibRjbRgbRcbLgbLibLcRsbRgbRiLsbLsbLgbLsLssbLgLsbLgbLibRjbLgbLsLssbLgbLsbLsLssbLgRsRssbLibLibRsbRsbRsbRsRssbLsbLsbLgbRgbLibRgbRgbRgRibLgbLgbRjbRgbLsbRibRgLsbRsbRibLgbLibRibRsbRsRssbRiLsLssbRsbRibRhbRgbLjLssbLibRibRibRsbRgbRjbRjbRgbRgbRjbRjbRjbRjbRjbRjbRgbRsbLibRsLibRsbLcbRjbLjbLjbLhLsbRhbLcLssbRhLsbLibLhbLjbLibLsbLgbRsbRsbLsbLjRsbLibRsRssbRsbRgbRib

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:23;Drug:CNO10microMApo0.5M
bRhbLjbLebRebLgbLjbRebLibLsbRhbLobLcbLjbLibLgRsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:24;Drug:CNO10microMApo0.5M
bLibLjLssbLobLebsbRibRsRsRsRssssbLgLsbLgbsbsbLibLsbRcbRsbRgbLjbLebLibRiLsbLsbRjbLcbLjRsbRobRobLgbRhbLibRsRibLsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:25;Drug:ControlApo0.5M
bRibRebLibsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:26;Drug:ControlApo0.5M
bRibLjLssbLcbRibLcbLgbRibRsbLiRsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:27;Drug:ControlApo0.5M
bRjRssbLjRsbLhRsbRjbRgbRsbLgbLsbRgLsbLibRgbLgbRgbRgbRibRcbLobRjb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:28;Drug:ControlApo0.5M
bRgbLobRsbRibRgbRhRssbRgb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:29;Drug:ControlApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:30;Drug:ControlApo0.5M
bLjbRsRsRsssbLsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:31;Drug:CNO1microMApo0.5M
bLcbLebLjbRebRebLobLobLgbsbLgbRebRsRssbLhbRebReRssbLjLsLsssbLjRsbLsbRsbLobLgbRsbLebRcb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:32;Drug:CNO1microMApo0.5M
bRgbLgbRgbLibRibRibLsLssbLgbRgbRcRssbRgbRgbRiLsbRibLcbLobRcbLobRsbLob

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:33;Drug:CNO1microMApo0.5M
bRoRssbLoRsbLjbReLsbRgbRsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:34;Drug:CNO1microMApo0.5M
bLsLsLsssbRoLsbLibLiRsbLgb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:35;Drug:CNO1microMApo0.5M
bLjbRhRssbLibLsLssbLgbRgbLsbLcbLjRsbRsLsbRibLhbLsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:36;Drug:CNO1microMApo0.5M
bRiRssbLibsbsbRcbLcRsbRgbLibRsbRgbLcbRibRcbLsbLsbLiLibLobRcbRobLgbLiLsbLobRcbLiRsbsbRib

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:37;Drug:CNO3microMApo0.5M
bsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:38;Drug:CNO3microMApo0.5M
bLgbLsbRgLsLsLsssbRjbRsbLcbRcbLhbLiLsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:39;Drug:CNO3microMApo0.5M
bsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:40;Drug:CNO3microMApo0.5M
bRibLjbRibLsbRibRoRssbLgLobLjbLhbRobLsbRgbLcbsbLibLsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:41;Drug:CNO3microMApo0.5M
bLoRsbLgbLobLgbRhbLobRgbRhRssbRibRibRobRjbRcLsbRcLsbRsLsbRhbRobLibRob

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:42;Drug:CNO3microMApo0.5M
bRhbLgbLsLssbLcbRjRssb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:43;Drug:CNO10microMApo0.5M
bLjbRhbRebLobRebLebRcRssbLhLsbRgb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:44;Drug:CNO10microMApo0.5M
bLgbRibLcbRgbRibRhbLsRsLsbLjb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:45;Drug:CNO10microMApo0.5M
bRobLibLibRcbRibLcbLibRsbRgbLibLgbRibLibLgbRsbLsbLsbLgbLiRsbRcbRcbRhLsbLsLssbLcbLhbLcbRsbLiRsbLobLibLhbLibRibLibLibRebRibLjbLjbLibLhbLibRibLsbLsbLibLibRjLsLssbLibLgbLsbLsLssbLgbLibLibRibLsbLibLibLsbRcbRibRobRibLiRsbLsbLgbRobRhbRcLsbLgbLiRsbLsbLgbLgbLibLgLsbLsbLgbLgbLibLibLibLgbRobLcbLjbRibRcbRibRgLsbRsbLcbLcbRibLcbLibLsbLgbLsbLsbLiLsbLgbLgbLgbLsLssbLgbLibLsbLgbLhbRhbLsbLgbLibLibRibLibLsbRhbLibLgbRsbRgbLibRobRoLsbRcRssbRibLobLhbRjb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:46;Drug:CNO10microMApo0.5M
bLgbLoRsb

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:47;Drug:CNO10microMApo0.5M
bLob

>ZFRecording2016-03-21;tW:300s;Start:133229;End:133729;Recording:4-1;Individual:48;Drug:CNO10microMApo0.5M
bRsLsbLcbRibRgbRjbRibRibRjbLobLjbRebLsbRobsbRoLsbRhb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:1;Drug:ControlApo0.5M
bRobLob

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:2;Drug:ControlApo0.5M
bReRssbLibRibLsLibRibLgbRgLsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:3;Drug:ControlApo0.5M
bsbLsbLsbLsbLobLobLjbLcbRhbLcbRcbLjbLhbLgbRsbLgbLhbLcbLibLibLibLibLjbLgbRgbRgRssbRsRssbRgbRsbRsbLjbLibRibLjbLibLjbLcbLibRsbLibLgbLibLibLsbRsbLsbLibRhbRcbLhbLiLsbLgbLgbLibLibRgbLgLsbLgbLgbLsbLsbLibLsbLgbRcbRjbRcbLcbLcbLjbRcbRsbRsbLobRcbRibRibLibLjbRobRibLjbRjbRibRibLibRibLjbRcbLcbLjbLcbRobLibLgLsbRobsbRjbLhbRcbRsbRcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:4;Drug:ControlApo0.5M
bRgbsbRcRssbLoRibRgbRhbRobRjLsbRoLsbRobRiRssbRobRoRsLssbRibRcbRgbRhbRgbRgb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:5;Drug:ControlApo0.5M
bRobLsbRsRcbLoLssbRobRebRsLiRgbRcbLjbRcbRobLgbRebLgbRsbRcbRgRssbRcbRcbLeb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:6;Drug:ControlApo0.5M
bLgbLgLsLssbLgLgLsbLibLibLiLibLjbsbRgRssbLebLsbLiRsbRcbRiRssbRgbRgbRgbLjbLjbRobLgLsbRiLsbRgRssbRsLsbsbLsbLsbLgbRiRssbRibRgbLibLobRibRgbRgRssbRgbRsRssbRgRsLssbRsLsbRobLgbRsbLsbRcbRebRob

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:7;Drug:CNO1microMApo0.5M
bRgbRoLsbRsbRcbLhbLebRgbRobLoRcbLsbLibLobRsbLsbLsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:8;Drug:CNO1microMApo0.5M
bRiLsbLgbLsLssbLgbRsbLgbLgbRjbLibLgbRcbRibLjbLjLssbRgbRhbRgbLcbLibLsbLgbLhbLgbLgLsbRgRssbRiLsbLgbLjbLgbRgbRibLiLsbRibLsbLgRsbRibRibLgbLsbRsbLsbRjbRcbLjRsbLibLsbRjbLjbLgbLibLibLibLgbRgbLibLgbLsbRibLgbLsbLgbLjbRibLjbLjbLibLgbLsbRgbLgbLgbRsbRsbRjbRcbLjbLjbRjbLhbLgbRgbLgbRjbLjbLjbLibRjLsbRsRssbLjbLibRjbLibRgbRjbLjbRsbRsbRjbLjbRjbLjbRjbRibRjbLjbRsRiRssbRibLsbRsbLibRjbLibRjbLjbRibLgbRsbRsbRsbLjbRcbLgbRibLibRjbLjbRjRssbRcbRgbRiLsbLjLssbRjbRsLsbLibRjbRsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:9;Drug:CNO1microMApo0.5M
bRjRssbRhbLhbRjRjbLibLibRgbLibLgbRibRibLibLsLssbRcbRibLjLsLsssbRcbLcbLcbRjbRibLjbRjRssbRibLsbLcbRibsbLhbRobRcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:10;Drug:CNO1microMApo0.5M
bRsbLsbLjbRibLcbRibLjbLibRibLsbLgbRebLobRsbRsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:11;Drug:CNO1microMApo0.5M
bLibLibRcbLibRibRjbLcbLgbRcbLhbLibLobRibRgbRibLgbRcbRgLsbLcbLibRibRibLibRjLsbRgbRsLibLobRhbLjbLcbLoLsRssbLibRsbRcbLoRsbRibRsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:12;Drug:CNO1microMApo0.5M
bLibRgbRgbRsbRsbsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:13;Drug:CNO3microMApo0.5M
bLsbRsbLsbLsbRebRsbLsbLgRsbRib

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:14;Drug:CNO3microMApo0.5M
bReRssbRcRsRsssbRcbRobRibRcbRibRhRssbRgbLoLssbRibLsbRibRibRsbRcRssbRcbRcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:15;Drug:CNO3microMApo0.5M
bLgRsbRobLibRcbLcbLjbLgbRjbLhbRcbLcbLibLibRjRssbLcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:16;Drug:CNO3microMApo0.5M
bLgbLcbLibRibRsbRgbLsbLibLibLgbLsbRsbRsbRjbLjbRibRjbLhbRjRssbRgbLjLssbRcbRcbRcbLiLsbRsbRjbRobLcbLcbRjbLebRjbRjbRibLibLgLsbLhbRcbRibLhbLjbRjbRcbRobRcbRjbRjbLcbRibLsbRjbLcbLcbRoLsbRibLgbRibLebLcbRjb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:17;Drug:CNO3microMApo0.5M
bLjbLgLsbLoRsbLibRibRsbLgbLgbRgbLibLgbRgbRjbLjbLsbRsbLibLcbLgbRjbLhbRgbRobRjbRgRgbLibRgbLeLsbRcbLibLibLjbLibRobRhLsbRibRsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:18;Drug:CNO3microMApo0.5M
bLibRibLjbRgbRibLjLssbRgbsbLebLibLcbLsbRgbLgbLibLgbLgbLibLcbRgbLhbLsLebsbLibLsbLibRgRssbRsLsbLgbLibRibLib

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:19;Drug:CNO10microMApo0.5M
bRibRsbRibLhbLibLsbLgbRsbRsRssbLsbRibRgbRgbLgbLgLsbLjRsRssbLibLgbRibLgbLsbLsbLgbLibLgbRebRhbRibRhb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:20;Drug:CNO10microMApo0.5M
bLiRsbRhbRebRgLsbLebRoRssbRcbLcbRhRssbLgbLsbLcbRcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:21;Drug:CNO10microMApo0.5M
bLgbLsRjbLobRiLsbRsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:22;Drug:CNO10microMApo0.5M
bLcbLobLibLcbRibLjbLcbLcbLsLibLgbLibLsLssbLibRjRgbRsbLcbRcbLibLjbRibLcLssb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:23;Drug:CNO10microMApo0.5M
bLibLobRcbRib

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:24;Drug:CNO10microMApo0.5M
bRibRsRssbLgbRgbRsbRgbRibRibRcbLgbLjLssbRebsbRsRssbsbRsbsbRsbsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:25;Drug:ControlApo0.5M
bRibRjbsbsbsbsbsbLsbLsbsbsbsbsbsbsbLsbsbsbRsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:26;Drug:ControlApo0.5M
bLsbRcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:27;Drug:ControlApo0.5M
bLgbLgbLhbRibRgLsbRjbRobRcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:28;Drug:ControlApo0.5M
bRsbRibRibRgb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:29;Drug:ControlApo0.5M
bsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:30;Drug:ControlApo0.5M
bRoRsRsssbRsbLsLssbRebRebLhbLsbLcbLsbLebRobRobRsbRobLebLoRsbRobLsbRsbRsbRobRsbLsbLebRebLobRcbRebRsbLobRobLsbLsbLsbLebRobLsbRobRgbLsbLsbLebLobRebRibRebRobRobRgbLebLsbRsbLobLebLobLebLobLgbRjbLibRobLobRgbRgbLebLsbLebRobLsbLobRobLhbLibRobRcbRobRibRebRebLgbRobLgbLobLobLobRebLsbLebRjbRsbRjbRgbLcbLobRobRobLsbLgbLcbLcbLebRobRgbLebRebRcbLebRobLcbLobRobRsbRsbLebRebRibLsbRobRobLibRcbLcbLobRebLebLgbLsbRebLobLsbRobLgbLobRebLgbLobRjbRjbRebLcbRebLebLibRebRebLebRobRobRibRjbLibRobLcbLobRobRsbRsbRibRgbRebRcbRobRhbLobLcbLibRobLobRgbLebRobRobRcbRebRibLcbRobRcbLibRsbLobRobLibLibLgbLobRebLobLebLgbRebLibRobLebRhbLobLobLobLcbLebRobRobLobRjbLhbLobLebLebLcbLobRobLebRhbRebLobLcbRobLobLgbRebLsbRebLebRobRibLibRcbLobRobRebLobRjbLsbLibRgbLsbLobRcbRcbRebRobRcbLobLsbLgbLgbLobRcbLebLgbRobLcbRobLgbRebRhbRobRebLebRobRibRcbRebRcbLobRebLobRobRobLebRobLebRibRobRobLgbLobLobLebRebRgbRobRibLobLobLebLobLebLebLcbRobRobLobLobLgbRebRibLobLobRobLobRobRsbLsbLebLebRsbLcbLobRgbLebRebRobRobLebRibLobRibLebRobLcbRsbRibLibLebRcbRgbLcbRebLobRebLibRcbLebRsbLebLibRobRobLcbRebLobLobRebLebRcbLhbRebRsbRebLgbRobRhbLobRebRgbRobRebRobRsbLebLibRgbLobLebRobLibLcbLcbRobLcbRobLsbRobLobLebRebRobRobLebRobLobLobLobRcbLobRobLcbRcbLcbRebRsbLobRsbRsbRobLebLcbLcbLobRebRebLebRibLebRobRsbLibRobLobRgbRebRgbLsbLgbLebLgbLcbLebRobRebLcbRebLobLobRgbRgbRobRobLobLobLobRibLgbRobRgbLobRsbRobLcbRebRobLobLibRobRibLcbLobLobRebLsbRobLebRobRobRsbRgbLibRobLobRgbRsbLsbLebLobLobRobRobLgbLsbRobRobLebRobLgbRobRebLobRsbRobLobRebRcbLobRobRobLsbRcbRcbRebLgbRebLebLsbRebRebRsbLsbLsbRebLobRsbLebRcbRgbLibRibRhbRobLobRsbRsbRebLgbRjbRgbLhbLobLsbLobRcbLobRibLobRebLobLobLobLsbLebLsbRibRobLsLobRebRobRobRebRobRobRsbRsbLebLsbLsbLobLebRjbLsbLibLgbLcbLobLsbRgbRibRcbLobRobLebLjbRjbRobLsbLsbRebRobRobRobRobRebRebRjbRcbRobLobLsbLebRsbLibRsbRebRsbLebRobRobLobRsbRobLsbRebLsbRebRsbRsbRsbLcbRobRebRebRobRobLobRebLsbRoLsbLsbLsRebLsbRsbRgbRobLsbRobLsbRobRobLobRsbRobRcbLobRsbRsbRebLgbRobRcbRobLebRebRjbRobLobLebRsbLsbLobRobRobRjbRcbRobLcbRebLobRjbRgbLebLsbLsRebLebRebRobRobRjbLsbRobRjbRsbLsbLobRobRcbRsbLobRsbLebLobLebLsbLeLebLobLsbLobRsbRsbLib

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:31;Drug:CNO1microMApo0.5M
bLsLssbsbLibRebRjRssbRobLjbLsbLobRibLhbReb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:32;Drug:CNO1microMApo0.5M
bRsbLsRgbLibRgbLhRsbLhbLoRhLsbRhbRcbLcbRgRssbLib

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:33;Drug:CNO1microMApo0.5M
bLcLssb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:34;Drug:CNO1microMApo0.5M
bLgbRsbLsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:35;Drug:CNO1microMApo0.5M
bLhbReLsbLsbRsLsbLsbRcbRibRjbLobRiRssbRgbRobRebLcbRobLsbRsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:36;Drug:CNO1microMApo0.5M
bRgbLibRgbLhbRsLsbRgLsbLgbRgLsbLjLssbRgbLgbRsbLcbLjbLiLsbLgbLibRob

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:37;Drug:CNO3microMApo0.5M
bRobLhbRebLcbRgbRibRcbLobLcbLebLcbRobLebRgbRebLobRobLcbRobLsbRebLobLobLobLobRobLhbRebRobRcbRebRcbRobLibLobLebRebRcbRebRibRebRobLobRebRebLebLhbLobLgbRcbLcbLcbRcbRcbLebRcbLibRsbRebRobLebRobRebRebRsbRibLcbRibLebRgbRebRobLibRobLcbLibLobLcbRobRebLibRcbRcbRibLebRebRobRebRobLobRebRobRebRebLcbRobRsbLgbRebLcbRebRobLebLibRobRebLgbRebLebRobRjbLobRcbRebLgbLibLgbRobLobLibLcbLhbRgbLobRobRobLobRibLobLobLebRebLobRibLebRcbLcbLobRobRebLibRsbLebLcbLebRcbLebLobRhbRcbLobRcbRhbRobLobLobRgbLobRobRebLsbRebLebLsbLobLebLhbRgbLebRobLobRsbLobLibLibLobLebRsbRobLobLcbLsbLobRobLebRgbRobRobLibRobLobRobLobRhbRebRebLobLebRebLebRobRgbRobRhbRobRobLgbLobRgbLcbRobRcbLobRobLobLebLebRibRsbRgbRebRobLebLgbRebRobRobLibLobRcbLobRcbLebRebRebLobLcbRobRcbRobRobRibLibRebRhbRcbLobRebLobLobLobRobLebRibRobLhbLebLobRobLobRebLobLebLcbLobRobRjbLebLobLsbRobLobRobRcbRebRibLobRebLobLcbRibLobLcbLebRibRsbLjbLobRebLcbRgbLibRibLgbRhbLebLcbLebLobLobRobRobRobRebRebRobLjbLebLcbRibLebRcbRcbLcbLgbLgbRibRobLobRobLobLibLobRobRobRobRebLebLebRebLebLobLcbLobRibRibRobRgbRobLobRgbRobRgbLobLebRebRgbLcbRcbLgbRcbRcbLcbRcbLcbRobRcbLcbRobLgbLobRsbRebLobLibRobLobRgbRhbRebRebLibLebLcbLobRibRcbLebRcbLcbLibRcbLebRobLobRobRebRcbRebLebRebLebRebLobLcbLcbLobRebLgbRibRobRgbRebLebRobLobRebLcbRcbRgbRgbRobRobRobLibRebLobLobRibRobRobRebRibLibRebRebLibLebRcbLsbLibLobRebLebRsbRebLobLebRebRobRcbRobLsbLcbLgbRebRebRobRibLcbLobRobRebLobLobLcbRcbRgbRobRebLgbRibLobLobLcbRobRobLgbLsbLcbLhbLebLobRebLebRobRobLebRcbLcbRobLobRsbLobLebRgbRibLgbLobLobLobLobLobRibLobLebRobRcbRibRcbRsbLibRobLebLobLibLsbRibRobLobLobRobRsbRibRcbRobRobRcbLobLebRcbRebRobRsbRobRebLcbLcbRcbLsbLebLobLsbRobLobRobLebLcbRhbLibLhbLhbRsbLcbLobRobRebLgbLebLcbLebRobRcbRcbLobLobRgbRibLobLobLsbRsbLebRobRobRcbRobRebRebLobLcbLsbLobRobLebRobLebLcbLobLcbLibLobRobLibRobRebRcbRobRobRebRcbLcbLebRobRgbRobLobLcbLobLobRgbLobLobLobLcbRebLobRobLibLobLgbRcbLsbRobLcbRebRobRobRobLobLobRebRobRgbRibRhbRgbLebLobLcbRcbLebLgbRebRebRebLobLobLobRobLebLobLobLhbRhbRobLibRsbRsbLhbLcbLcbRebRsbLobRhbLebRhbRobLjbRobRebLebRobRebRobLhbLcbRobRibRobRobRebLebRibLgbRobLobRgbRobLsbRobRgbLobRobLcbRebLobLibRobRebRebLcbLcbLobRobRobLibRobRibLgbRobRobLobRobLibLobLobLcbRsbRebLobLobRgbRobLcbLebRobLobLebRobRobLobRibRibRhbLebLcbLsbRobRobRobLibLebLobLebRgbLobRebRobRebRobLebLobLobRebLobRgbRibRcbRobRobLobLobRcbLobRobLobLobLobRebRobLgbRobLobLcbLebRcbLobRobRcbLgbLobLcbLcbRibRgbLobLobLobRobRobLibRobRcbRcbLobLgbLebLobLobLgbRsbLobRgbLcbLcbLebLobRebLcbRebRebLobLebLibRcbLobRobRcbLobRcbLobLobRsbRcbRobRobLgbRgbLobRobRgbLobRobLebLhbRsbRobRobRobLcbLibRebLcbLebLobRgbRobLobLobRobRobLcbLebLebLobLebLgbRebLobLcbRebLobLebRobRhbLobRobRibLobLebRhbLgbLcbLobRhbLcbRcbLcbRcbRebRobRobLobLcbRobLgbLcbRgbLcbRobLgbRobLhbRibLobLobRobRsbLgbRobLobRobLebLobLcbRebRobRgbLsbLobLobLebRobLhbRobRgbLebLsbLobLobLebLobRebLobLibRobRobRobRebRebLobRsbRibLobRcbRgbRebLobRebLobRcbLebLobLobRcbRobRobLibLobRsbLcbLhbRobLobLobRebRobRobLgbLobRibRibLcbLobRobLgbRhbLobRobLobLebLobRcbRcbRcbLgbRobLcbRebLjbRcbRobRebLgbLobLobLebRobRobRobLebRgbRcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:38;Drug:CNO3microMApo0.5M
bRsbLiRsbRsbLsbLgbLgLsbLibLgRsbsbRiLsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:39;Drug:CNO3microMApo0.5M
bRibLebRebRobLibRcbRcbRobLebLebLibRobLebLebLebRhbLcbRjbRebRcbLebRibRebLebLcbRgbLobRobLcbRobRobRsbRgbLebRobLcbRobRebRebLobRcbRobLebLhbRhbRobLgbLgbLcbLobRebLhbLebRebLebLcbLobRebRobRobRobLebRcbRobLcbRobLhbLobRibLobLibLebLibLsbLibLobLibLebLobRobRcbLcbRobLobRgbRcbLebRebRebRobRcbLobRebRhbLhbRobRobLobLibLebLjbLobLjbRibLebRgbRgbRebRcbLebRcbLhbLebLobRobRcbRobLcbLobRebLobLgbRebRebLobLobRibLobRcbLgbRcbLsbRobLobLebRcbRobRobRebLobLebLobRcbRcbRgbLebLobLobLsbLsbRcbRobRhbLcbLobLobRobLobLobLsbLebLobRgbRcbLebRobLgbLobRobRebLobRebLibLcbLgbLobRhbLebRibLobLobLgbLobLobLobLebRobLgbRibRobRebRcbLobRgbRobRobRobLobLibLcbRobRebRebLibRcbRobRobRcbRhbLebLobLebLsbRcbLobLobRibLobRobLobRebRobLcbLobRobLebLobRsbLobRobLobRebLobRebLobRibRebLibLobRibLobLobLgbLobLgbRibRcbLebLcbLebRcbRibLobLebLobLobLsbRebRgbRobLobLcbLcbLcbLobRebRebLebLcbLibLcbRibLebLebRobRobRebLebLobRobRebLebRebRibLobRobLobLcbRibLobRobLobRobRobRobLobLobLibLobRebRcbLobRobRobRebRobLgbLebRebRobRcbLcbLcbLobLobLgbLsbLobRcbRobLebLebRcbRobLebRcbRibLobLebLhbLobLhbRobRcbLcbRebLibRobLjbLebRobRebRobRebRobRobLibLobLebLebLgbRsbRebLgbRobRobRcbRcbRobLcbLebRcbRobLobLcbRobRobLobRobRobRobLebLobLobLobLebRsbLobLgbLobLebLebRobLhbLobLcbLgbRibRibRcbRobLobLobLgbRobRebRibLobRobLobLobRibLebRobRebLobRsbRibRobLebLobRobRobRgbLobRibRcbRobRobRibLcbLebRgbRhbLibRcbRobLebRobRebLobRebLobLebLgbLebRobRebLebLhbRobLobRobLobRobRibRcbRcbRobLebLobRibLobRibLobLebRobRobLebRebRobRobRibLibLebLcbRebLibLobRobRibRebLobRobLebLobLobLobRobLobLebLobRsbLcbLcbRebLgbRgbRebLcbLibLibLobLebLobLebRcbLobRebRobRibRebLhbRobRebLebRobRebRebRebLsbRobLobLcbRebRobLobRobLobRobLebRobRebLebRobLobLobLcbRobRgbLobLebLhbRobLobRobRcbLobLobLcbLobLhbRcbRobRibLebRhbRebRobRebLobRcbLobLcbRcbRgbRobRcbLibRgbLsbLebLobLobRobLcbRebLobRobLgbRcbLebLsbLgbLobRgbRobLgbLcbLebRobRebLcbLcbRebRhbLobRgbRobRebLebRebLgbRebLcbRcbRobLobLebRebRgbRibRebLobRobLobLobLobRebLebRibRsbLibLsbRobLobRobLobRobLcbRebLebLibLobLobRcbLebRebLobRobRobLobRebLgbRibRobLhbRebLcbLebLobRobRcbLcbRibRebRibLibLgbRebLebLobLobRsbRcbRcbLobLebLgbLobRcbLobRobLobRobRobRibLcbLgbLcbLgbRcbRjbRcbLobLhbLgbRobLcbLgbRebRcbLsbLebRobRgbRobRcbRobLibRebLobRebLsbLobRhbRebLobLebLcbRobRibRebRgbLebLobLobLcbRebLibRcbRebLobRcbRibLibRobLcbLobRebLebLsbLebLebLobLsbLebLobRhbLobLcbLobLobRobLcbRebRgbRebRebRgbLobRobLobLobLgbLobLibLebLcbLobRebLobRcbRobRobLsbRobLobLgbLobLobLobRgbRibRobLobRibRobRgbLcbLobLobLibLobRobLobRcbRobRobRcbLebRcbRcbRcbLcbRgbRobLobRobRobRobRobRobRcbLsbRcbRobLobRibLgbLibRsbLebRebRobLobLebLcbRebLhbRobLebLobRobLebRebLobLibLobRobRebRgbLobLsbLcbLobRebRgbLsbRobRibRcbLobRebRibLebRobLobRcbLibLobLebRobLobRobLobRobLobRebLobLobRhbLobRobRobLcbLhbRobLobLcbRebRobRsbLobRcbRcbLgbLobLebLibLobRebRebRcbLobRobLgbLebRebRobLobLsbLcbLebLebRebRjbLgbRgbRcbRebRobRgbRcbRebLebLcbLobRobLcbLsbRsbRobLcbLebLebRsbRobRsbRhbRebLcbLobLebLobRgbLgbLcbLobRebRobLgbRibLibRobRcbLgbLobRebLcbRhbLebRcbLebLebRsbLcbRobLibRcbRobLebRcbRobRsbLobRcbRobLobLgbLobRobRebRobLhbRobLobLobRobRobRobRgbLobRebRgbLebLebRobLcbLobLebRebRebRsbRhbLcbLebRobLobLobRebRcbLebRebLobLebRibRobRcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:40;Drug:CNO3microMApo0.5M
bLobLjbLcbLcbRsbRobLcbLgLsbLebRibRiRssbLcbRjbRoRsRggbRsbRibRsbLsbRsbRsbLsbLgbRgbRibLsbLgbLcbLibLibRgbLobRgbLgbRsbRgbLsbLcbRjbLibRobRcbRhbRoRssbLibRjbLcbLcbLgbLsbRsbRsbRsbLsbLsbRsbLibLibLgbLsbLjbLibLjRsbLgbLsbLjLssbLsbLgbLgbLgbLgbLsbLiRsRiRssbLhbRibLjbLjbLibRcbLcbRjbLsLssbLobRibRibRobLibRgbLsbRgbLsbRgbLsbRsbLgbLsbRcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:41;Drug:CNO3microMApo0.5M
bLcbLibLibLsbLsbRoRssbReRssbRgbRgLsbRibRsbRibRgRssbRsRssbLcRsbLcRsbRgbRjbRibLjbRsLiLgLgLibLiLebRsRssbRjbRcbLobRcbRibLibRibRjbRcbRoLsbRhbRobLibLgbRsRssbLsRibLcbRjbRobRibRibRcLeLsbLgLsbLsbLsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:42;Drug:CNO3microMApo0.5M
bsbsbRcbLhbLsbLjbLobLgbLiLsbLcbLebLobLobRjRssb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:43;Drug:CNO10microMApo0.5M
bLsbLsRsbLsbsbRsbRsbRsbRjbLobLiLsLssb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:44;Drug:CNO10microMApo0.5M
bRgbRsRgbRcbLibRjLsbRgbLobLgbLhRsbLibRgbLcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:45;Drug:CNO10microMApo0.5M
bRobRcLsbLhbRcbLcbLgbLgLcbRobRibRcbLhbLcbLcbLhbLibLibLhbLhRsbLibRibRcbRcbLibLibRgbRsbLgbLiLsbRjbLcbLibLgbLgbLsbLhbRiLsbsbLgbLsbLgbRsbLhRsbLibLgbLibLibLibRhbLibRgLsbLobLibLsbLgLsbLgRsbLibLgRsbLgRsbLgbLgbRsbLgbRgbLibLib

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:46;Drug:CNO10microMApo0.5M
bLeRsbRjbRibLgbRsbRsbRsbLsbsbsbsbsbsbsb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:47;Drug:CNO10microMApo0.5M
bLgbRcb

>ZFRecording2016-03-21;tW:300s;Start:133731;End:134231;Recording:5-1;Individual:48;Drug:CNO10microMApo0.5M
bRoLsbLgRsbLcLssbRobRibLcbLibRsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:1;Drug:ControlApo0.5M
bLjbLibRjbRcbRcb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:2;Drug:ControlApo0.5M
bLibRgbLsbRibLgbLobRobRgbRjbLebRsbRibLsbLgbRcbRibLibLgbLob

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:3;Drug:ControlApo0.5M
bRjbLgbRibRobLibLgbLhbRhbRibLcbLgbLjbRibLibLhbRgbLgbLgbRsbRobLhbLjLssbLibRgbRsbRjbRhbRsbRebLebLhbRebLebRibRibLibLgbRibRsbLsbRsLgbsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:4;Drug:ControlApo0.5M
bLibLcbRibRib

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:5;Drug:ControlApo0.5M
bLsLgbLjbLsbLcbRibLib

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:6;Drug:ControlApo0.5M
bRsbsbRsbLsbLsbLsbLobRgbRoRssbLebRgbLsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:7;Drug:CNO1microMApo0.5M
bLobRebLebRsLobRibLgLsbRcbLobLsbLobLibRjbRhbRcbRcbRobLjbRsbRcbLcLssbRibLsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:8;Drug:CNO1microMApo0.5M
bRibLjbRjbLcbRjbRjbsbLcbRcRssbRibRsRssbLibLoRsbRjbRebRibLjbLcb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:9;Drug:CNO1microMApo0.5M
bRobRgbLgRsRssbLiLsbRibLibRgLsbLgbRibLhbRibLjLssb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:10;Drug:CNO1microMApo0.5M
bRebRcbLiLsbRobRobRhbLcbLhbRoRssbRhbLjbLobLebLebRjbRcbRobRebLgbRsbRjbLsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:11;Drug:CNO1microMApo0.5M
bRcbRhbRsRgbLobRibLcLssbLibLibLibLcbRjLsbRsbLcbRgbRiLsbLgbLcbLcbLhbLibLgbLgbLibLcbLcbRsLhbLhbLjbLcbLibLjbRgbLibLiLsbRcbRsbLib

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:12;Drug:CNO1microMApo0.5M
bRcbRibRibRibRgbRgb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:13;Drug:CNO3microMApo0.5M
bLebLcbRobLsbRcb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:14;Drug:CNO3microMApo0.5M
bRcbRcbRcRsRsssbRibRcbRcbLhRsbsbRjbRibRoRssbRcbRcbRgb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:15;Drug:CNO3microMApo0.5M
bRcbLjbLcbLibRibRibLsLssbRjbLgbRibRibLjbLjbLibLhbLjbLhbLibLobLjbLgbLoLssbLjbLibRcbLcbLibRhbLjbRjbLjbLjbLjbLjbLgbLibLgbLibLsbRgbLjbRjbLjLjbRjbRcbLjbLjbLibLcbLibRibLjbLiLsLssbRjbLobLibLjRsbLhRsbLgbLjbLgbLgbLgLsbRgbLsLssbLgbRgbLgbLibLgbLsbRgbLsbLjLssbRcRobRjbRibRibRsbLsLssbRgbLsbLgbRhRssbRgbRsbRgbRgbRgbRgbRgbLgbRgbLsbRgbRibRsLsbRjbRibRgbLsLsLggbRjRssbRgbRsbRsbRgbRgbRsbRsbRgLsbLebRjbRobLjbRjbLjbRgbLcbLcLssbRjbRjbRgbRgbRgLsbRgbLgbRgbRsbRgbRgbRsLsbRgbLsLssbRgbRsbRgbRgbLsRsbRjbRgbRibRgbLsbRgbRsbLgbRcbRgbRsbLsbLsbLjb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:16;Drug:CNO3microMApo0.5M
bRjbLcbRobRhbLjbLsRsbLgLsbLibRibRsLjbLcbRcbLcbRhbRibRcbLib

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:17;Drug:CNO3microMApo0.5M
bLjbRibLgbRsbLibLjbRhbLibLibRoLsRsbRibLgRsbRjbRcbRhbLjbLcbLibLibLibLgbLsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:18;Drug:CNO3microMApo0.5M
bLhLsbLgbLhbLibRgbRgbRibRhRssbLsbLgbLsbRsRssbRsbLsbRsbRsbLibRsLsLssbLiRsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:19;Drug:CNO10microMApo0.5M
bsbLcbLgbRiRssbRibRjRsRsLsssbLjbReRssbRibRsbRjbRgbLjbRgbRgbRjbRhbRgbRgbLgRsbRsbLsRsbLibRibRjbRib

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:20;Drug:CNO10microMApo0.5M
bLjbLjbLcbLhbLcbLibRsbRobLsRsbRebRhbRobLsbLgbLgb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:21;Drug:CNO10microMApo0.5M
bRibRibRjRssbRibLobRibRibRiLsbRcbRgRssbRibRhbRoLsbRobRibRgbLsbLgbLgbLgRsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:22;Drug:CNO10microMApo0.5M
bRiRssbRcbLibLebLibLibLibLsbRsbLibLgbLsbRgbRsbRgbRgbLibLiRsbLibLgRsbLibLiLsbLibRsbRsbLjbLibLibLsbRgLsbLsbRgbRgbRgRssbRgRssbLsbRgbRsbRsbRsbLjbLibLhLsbRiRssbLjbRibLcLsLsssbRobLib

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:23;Drug:CNO10microMApo0.5M
bRgbLebLcbLoLssbLibLcbLcbLcbLebLjLssbLcbLibLibLibRibLiLsbLjbLjbLibLgbLibLgbRjRssbRiRssbLib

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:24;Drug:CNO10microMApo0.5M
bsbsbsbsbRsbRsbLsbLsbsbLsLssbRsbLsbLoRsRssbLsbRsbLsbRsbRsRsRsssbsbRsRcbLjLssbRobRgbRobLsbRoRssbRsbRibRibLgbRgLsbLgb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:25;Drug:ControlApo0.5M
bRibRsbRibRsbLsbRgbRsbRsbLsbRsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:26;Drug:ControlApo0.5M
bLcbLibRobLjbLibLibLcb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:27;Drug:ControlApo0.5M
bLjbRhbsbLgbRobRjbLsbLjLssbLibRgbRgb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:28;Drug:ControlApo0.5M
bRjbRobLib

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:29;Drug:ControlApo0.5M
bRsbReRsRsssbLsbRsbLsbRebReLsbRebLsbLsbLebRobRjbLsbLebLcbRobLjbRobLsbRsbLsbRsbRebRebRebLobLibLsbRsRebRobRsbRsbLobRebLebRobRcbLibRebRhbRobRebLobRsbLobLebRobLobRobRcbRobLobLhbRcbRobRobLebRsbLcbLobLcbLobRjbLcbLebRcbRobRcbLobLebRibLcbRobLebLebLobRobLcbLobRobRgbRobLcbRobRebLobLibLsbLgbLobLobLibRebLobLsbRobRebRobLebLibLebLibLebRsbRsbRebRobLebRhbRebLebLebLebLobLobRobLjbLobRobRsbLcbLebLobLebLibRobLebRcbLebRcbLobRobRhbLcbRebLobRobRobLibLobLobRobRcbRhbLobLcbRobRibLobLobLobRobLobRcbRebRobLsbLobRebRobLobRobLibRsbLobRebLcbLsbRcbLgbLebLcbLibRobLcbLobLobLcbRcbLebLobLobRgbRobLobLebRobLibRibLcbLobRobLcbRibLobRobLebLebRebRibLhbRgbRobLobLobLebRobRebLcbRobRcbRobLgbRebLobRebRobLobLcbRebRobRobRgbRhbLebRibLobRobLcbLobRibLibRsbRobLobLjbRobRobLcbLebLobRobLibLgbLebRcbLsbLobLobRibLobRibLobLsbLcbLobLobLcbLebLobRsbRobLebRcbRibRobRobLcbRebRobLsbRgbRobLgbLobLebRgbRobLebRebLgbRebRobRgbRcbRcbRsbLobRobLobLobLebLebRgbLcbLobLibLobRebRobRobLobLebLobLebRobLobLobRcbRobLhbLobLgbRobLobRcbRsbLebLgbRibLobLebRobLhbRobRsbRcbLcbRobRibRobLsbLebRcbRobRobLobLobLgbLcbLobLebRobLgbLobLobLobLhbRobRcbLobRibRcbLibLebRsbLobRebLobLobLebRebRibLcbRibLebLcbRobRobLobLebLobRobLcbRibRobLebLcbRibRebRcbRcbRobRcbLcbRcbRobLebRcbLebRcbRgbRobLobRobLobRebRcbRobLebRobLobLsbLobLgbLgbRobRobRgbLibRsbRcbLobRobRibRobLebLebRhbRcbRebLobLcbLobRibRobLcbLebLobRgbLgbRhbRcbRibRebRobLobLsbLcbRcbLobRsbRebRcbLobLebLebRobRobRgbRebLobRcbRcbLobLcbRobRcbRebRgbLebLcbLgbRgbLobRebRgbRobLcbRebRobLibLebRsbLgbRebLebLcbLobLebRobLobLobLcbRebLgbRgbRcbRsbLgbLobLobLgbRobRebLobLgbLobLibLobLebLcbRobRobRobLibLobRobRcbLobRebRibLobRobLcbRcbRobLebRibLobLobLebRobRobLobLobLobLobRibLsbRibRobRobRcbRgbLebRcbLgbRobLibLebLebRjbLjbLebLobRgbRgbRebLebLgbLobRobLebRcbRebLcbLobLobLobLebLcbLebRebRgbRibLcbLobLebRebRsbLebRibLibRobLcbRcbRobRobLcbLobRobRhbLibRgbLhbLcbRhbLobRcbLcbRsbRcbRcbLibRebRgbRibRebRobLcbLcbLhbRcbLcbRobLobLobRobRobRebLobRcbRcbLebLibRebRobLebRobRcbRobLibRibRgbRobLebLebLobLobRobRgbLobLebLibRobLhbRobLebRobLobLobRibLobLsbRebLcbLobLobLsbRsbRobRobRobRgbRibLjbRobLobLcbLobLgbRcbRebRcbLibRebLobLobRgbLobRobRobLibRcbLibRebLebLobLebRebRgbLebLsbLobRsbLibLibLobRobRcbRcbLcbRibLebRobRobRebLebRobLobRgbLobRebLcbLobLcbRobRcbRobLebLebRcbLebRobRobRcbRgbRgbRobLibRcbLgbRgbRibLjbRebRcbRcbLobRebRgbLebRcbRebRebRcbLcbRobLobLobRsbLebLebLebRebRcbRcbRobRibRebLobRobRebRobRobLcbLgbRcbRgbRebLobLebRobRcbRebLcbRcbLobLcbLsbRobLebRebLobLobLobRibLobLobLobRobLebLcbLobLobLcbRebLobRcbRgbRobLibLobLibRobLebLobRhbRobRobRhbRsbLhbRcbLobRobLobLebRsbRobRobLobLobLobRebRobRibRobRobRgbRebLgbLobRebLobLebRebRibLhbRobLobLcbLobLgbLcbLebRsbRobRcbRobLibRobLsbLjbRcbLcbRobRebRcbRgbLcbLcbLobRebLobLobRgbLcbRsbLobLobLobRebRebLcbRobRebLebLgbRebRcbRcbRobRobLcbLobRebLobLcbRobLebRsbRobRobRcbRebLebRibLebRebLhbRibRebLsbRcbLobLebRobLobRobLobRobRebLobLobLcbLebRobRobRobRobRebRobLibRsbRsbRgbRgbLebRcbLobRgbRcbLobLobLibLebLebRebRgbLobRebLcbLebRobLobLobLhbLcbLobLsbRebRsbLsbLobLobLcbLibRobRobRibRobRibLibRobRobRcbRibRebRebRibRibLibLcbLobRobRobLobLobRebLobRebRobLcbLebRobLsbRob

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:30;Drug:ControlApo0.5M
bLcbRsRsRsssbLjbLsbLgbLgbLgbLibLgbRsbLgbLhbRjbLgbRsbLgb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:31;Drug:CNO1microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:32;Drug:CNO1microMApo0.5M
bRgLsbLebRobLcbLgbRgb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:33;Drug:CNO1microMApo0.5M
bLibLebRgbRebRobRjbLibLjbLsbLjbLsbLsbLjbRsbLebLsbRgbRjb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:34;Drug:CNO1microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:35;Drug:CNO1microMApo0.5M
bRiRssbRobLhbLsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:36;Drug:CNO1microMApo0.5M
bRgbLiLsbLgbRsbRsbLgbRjbLibLhbRgbLgLsLsLsssbLsLcbLjbLjbLibRhbLcbRibLib

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:37;Drug:CNO3microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:38;Drug:CNO3microMApo0.5M
bLsLsLsLssssbLiLsbRsbLgbLsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:39;Drug:CNO3microMApo0.5M
bRibLebRsbRobRebRcbLebRobLsbRsbRobRebRcbLebLebRcRssbRebLsbLgbLebRsbLsbRcbLobLobRgbLebLjbRebRgbRebRsbRebLobRebRsbLobRibLoRcbRobLobRebLsbRobRobLsbRobLobLebRebRobRebRobRebLobRibRebLcbRobLcbLobRsbLobRebRcbRobRcbRgbRobRcbLibLsbLsbRobLcbLobRebRobRobRebRgbLobRsbRobRebRjbLjbRcbLobRjbRobRobRebRobLobLebRebLobLcbLobLebRebRjbLebLcbLjbLobRebRcbRcbRebRsbRgbRobLsbLobRebRsbLsbRebLsbLebLjbRcbRsbRebRcbRcbRobRsbLobLebRebLcbLsbLcbLobLebRgbRebLjbRjbLsbLsbRobLobLcbRjbRebRebLobRebRobLebLobRcbRibLcbRjbLobLsbRobLjbLebLobRebLobLebLobRibLebLjLssbRjbLebRobLjbLobLobRobLebLcbLobRebRobRebRobRebRgbLgbRcbLjbLobRebLcbLsbRjbLobLobLobRsbRobLibRobLsbRebRjbRobLcbLsbRebLobLebLebLjbRebRjbRobLobLibRobRgbLsRobLebLjbLjbLebRobLebRobLebLobRebRobLobRebRobLobLebRobLgbLsbRjbLobRobLcbRsbRsbRsbRebRebRobLcbRsbLebLjbLobLjbRcbLibRobLsbLjbLsbLebRcbLcbLebLjbRobLcbLobLobLebRsbLobRobLcbRobRobLobRebRobLjbRobLjbRobLhbLobLebLobLcbRobRobRobRobRebRjbRobRobLebRobRobLobRsbRobRobLebRsbLobRebRebRobRcbRsbLobRsbRobRgbRobLobRgbRsbLobLjbRebLobLjbRobLobRobLgbLobLobLcbLobRoLgbRjbRobRsbLebLsbRebRobLobRcbRobRobRsbLjbRobLsbLobRibRjbRobRobRobLobLebLjbLcbLebRjbLebRcbRebRobLobRsbRobRobRobLgbRsbRobRcbRebRgbRebLobLsbLobLobLebLobLobLcbLsbRcbRobRobLgbLsbRobLobLsbLobRobRobRobRobRebLsbLebLobRebLobLsbLsbRobRebLobLsbRsbRsbRcbRobLsbRobLobLibLobRebRobLcbLsbLobRsbLjbRebLebLgbLebLcbRsbRobLobRebLsbLobRebRebLhbLobLebLsbRebLibRobRsbLobRobRebRjbRibRsbLebLobRobLobLebRjbLebRjbLjbLobRobLebRobLobRobRobRebLgbLobRobRobLgbLobLebLobLsbRcbLibLgbRibRobLobLcbLobLobLcbRsbRjbRjbLebLobLobRebLobLobRobLsbRobRobRcbLobLobRobLsbRsbRcbLebRebRsbLsbRebLcbRebRcbLobLobRjbRebLcbRebRobLobRcbLgbRgbLobLobLobRgbRebRobRebRobLjbLsbRcbRebRebLebLsbLobRobLobRobRobRobLobRsbRsbLobLjbLebLebRebLobRobRebLjbLebLobLebLgbLobRcbLgbLgbLebRsbRobLebRobRcbLobRsbLjbLobRebRebRebRobRebLobLobLgbRebRebLsbRebLebRobLgbRebLobRsbLobRsbLgbLobRobRobLebRobLobLobRobLcbRsbLobRobRibLebLobLobLobRobLobLcbRjbRobRobLobRcbRebRobRobLsbLobRsbLebLgbLibLebRobRcbRobLebLgbRobRjbRobRobRobLobRjbLobRobRcbLobLebRsbRobRobLobLobLoLobLobRebRsbRobLebRsbLobRebLgbRobLobRibRsbRgbLobLobRebLjbRjbLobRebLsbLebLoRjbRsbRgbLsbLcbRsbLibLobLobLibRobRobRjbLsbRebRobRebLobRsbRsbRebRebRsbLsbRhbRcbLobRoLsbLebLebLsRsbLebRobLcbLebRcbRjbRcbLcbLobLebLobRjbRjbRsbLebRobRebRgbLsbRjbRobRgbRcbRjbLebLsbLobLobLgbLebRsbLsbLebRjbRebRobRjbRobRobRcbRcbRcbLjbLebRcbRhbLebRebRcbRebLebRjbRebLgbLebRebRobLcbLobLsbLobLebLsbRobRjbRjbRobRsbLobRobLsbRjbLgbLsbRobRebRebRcbRcbRebRsbLsbLobRcbLobLebLebLjbLsbLobRobRobRsbLobRjbLsbLebLjbRsbRjbRobRobRebLobRobLobLibLgbLebRobRsbLebLobRebLobRsbLebLobLebRebRebLobRebRjbRobLsbLobLobRgbRebLoRebLsbRsbRebLjbRgbLibRsbRsbLsbLsbLobLobRobLobRibLebRsbLobLcbRjbLebRibRobLsbRobLjbLsbRobRjbLobLebLoRsbRsbLhbRebRibLsbRsbRebLsbLebRobLsbRobLobLjbLebRebRobLsbRcbLobLobLjbRsbLjbLobRjbRjLsbRsbLobRobRsbRsbLcRobLobLobLsbLobLebLebLjbRibRebLsbRcbRebRsbLsbLhbLcbRsbLjbRjbLgbLebRobLsbLsbRcbLobLibLgbRcb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:40;Drug:CNO3microMApo0.5M
bLsbLjbRcbLjbRjRssbRebRjbRjLsbRibRibRhRssbRjbRjbRcb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:41;Drug:CNO3microMApo0.5M
bLgbRsbRhRssbRgbLsbRibLobLgbLibLibRsbRsbRibRcbRcbLoLibLibRgRsRsssbLsbLjbLibLibLsbRoRssbLsbLgbRjbLeLsbRcbLobLgbLgbLsbRsbLsbLsLsRssbRgbRibRibRgbRsbLgRsbLsbLgbLgbLjbLcbLgbLsbLsbLsbLjb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:42;Drug:CNO3microMApo0.5M
bLcbRjRssbRjbRjbLjLssbRjbLsRsbsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:43;Drug:CNO10microMApo0.5M
bLsRsbsbsbLgbRebRsb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:44;Drug:CNO10microMApo0.5M
bLebsbLjbRsLsbLhb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:45;Drug:CNO10microMApo0.5M
bLcbRcbRhbRhbRsbRibRobLibLgbLsbRibRibLibLgbLibLcbLgbLibLibRcb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:46;Drug:CNO10microMApo0.5M
bLjbLcbLcLgbLibLsbRsbRsbLsbRgbRgbLhb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:47;Drug:CNO10microMApo0.5M
bLjbRcLsbRsRssb

>ZFRecording2016-03-21;tW:300s;Start:134233;End:134733;Recording:6-1;Individual:48;Drug:CNO10microMApo0.5M
bLgbRobRhbRibRibRibLhbRibRobRobRibRjLsbRsbRcbRibRcbLsbRobRobLsbRobRjbRibRiLsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:1;Drug:ControlApo0.5M
bRobRsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:2;Drug:ControlApo0.5M
bLjbRjRssbLcLssbLhbRjbLiLsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:3;Drug:ControlApo0.5M
bsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:4;Drug:ControlApo0.5M
bRcbRcbRebLebRjbRobRcbRibRibRgbRib

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:5;Drug:ControlApo0.5M
bLibRsbLobRcbLgbRhbRoRssbLgbRebLebLcbLgbRibRibRcbLsbReb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:6;Drug:ControlApo0.5M
bRgbRsbRsbRgbRobRobRsLsbLobRjbRgbRgbLsbRibRjbLsLobLsbRibLobRjbRjbRibRgbRgbLsbRibRjbRibRsbRobRsbLobLhbRjb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:7;Drug:CNO1microMApo0.5M
bRjbLibRibLsbLiRsbRibRcbRcbRcbRcbRgRssbRcbRcbRibRibRibLibRhb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:8;Drug:CNO1microMApo0.5M
bLcbRcbRcbRibRgbRsRssbRgbRgbLibRsbRjbLjbRsRjbRebLsbRgbRgbRjbRcbLgLsbLsbRgbRiLsLssbLibLibRibRgbLgbRgbRgbRibLjbRgbRibRhbRjbRcbRgbRgbRgbRgLsbRsbRsbRsbLsbRgbRgbRsbLsbRgbRsRibRgbLsbRjbRgbLgbRgbRibRgbRibLgbRibLibRsbRgbLgbRibLibRjbLjbRjbLjbRjbRobRgbRgbRsRssbRibRgbLibRibLibRsbRobRobRibRibLgbRsbRgbRgbRgbLjbRjbLgbRjbRjbLjbLibLjbRsRjRssbLibRibLibLgbRibLjbLgbRjbLjbRibLgRsbLjbRjbLjbLjbRjbLjbRjbRcbLjbRibLjbRibLsbRjLsbLgbRjb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:9;Drug:CNO1microMApo0.5M
bsbRsbRobRsbLjbRobLoLssbRhbLgbLgbLibRsbLgbRhbLibRib

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:10;Drug:CNO1microMApo0.5M
bRibRhRssbLobLebLsbLjbLobRobLjbRhbRcbRgbRgbRibLobRibReLgbRgbLcbLhbLjbRjbLebLcbRibRhbLobRobRsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:11;Drug:CNO1microMApo0.5M
bLcbRgbRgbRiRcbLgbLibLgbRsRssbLibRebRhbLiLsbLgbLjbRcRssbRibRgbRhbRjbRsLcbRcRssbLibLgbLgbLib

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:12;Drug:CNO1microMApo0.5M
bRsbRibRgbRsbLibRsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:13;Drug:CNO3microMApo0.5M
bLiRsLsRsbRhbLcbLgRsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:14;Drug:CNO3microMApo0.5M
bLcbRjbRcbRibRjbLcbRjb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:15;Drug:CNO3microMApo0.5M
bLcbLjbRjLsbRjbLsbLibRibRgbRibLibLgbLibLjbLibLjbLjbLibRibRhbLjbLibLiLsbLcbLhbLjLssbLebLibLebLibLcbRibRibLsbLsbLjbRhbLobLcbLcbLsbRjbLcbLsbRgRssbLsbLsbLgbRibRibLgLsbLgbLiRsbLsbLjbLgbRjb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:16;Drug:CNO3microMApo0.5M
bLcbRiRssbRibLibLsbRcbRobRobRcRssbRibLibRcRssbRibRibRcbRibLibRgbRsbRgbRibLcLssbRcbLjbLcbLobLcbLgbRjbRibRobRebLgbRgb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:17;Drug:CNO3microMApo0.5M
bLobLcRsbLhbLjLssbRcLsLcbRob

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:18;Drug:CNO3microMApo0.5M
bLgbRsbRsbRsbLgbLjbRebRibRgLsbLcLssbRgbLhbLibLibRgbLsbRgbLsbLsbLobRgbRibRgbRgbRgLsbRjbLobRjbLgbRgbRgbLsbRgbRgbRgLsbRsbRjbRsbLoRsbLhLsbLibLjbLibRgLsbRibLsLssbLgbLobRcbRsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:19;Drug:CNO10microMApo0.5M
bLgbRiRssbRibLsbLibLjbRibRjbRjbRjbRjbRcLsbLcbRobRcbRibRsbRgRssb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:20;Drug:CNO10microMApo0.5M
bLgbLsRsbLsbLibRjbLibRjb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:21;Drug:CNO10microMApo0.5M
bLsbLobLgbLgbLgbLgbLgbLgbRsLsbLjbLibRibRgbLjbLcbRiLsbRibRgbRgbRibRgbRibRjbRibLgbRsbLgbLcbRjbRhbLibLcbRcbRsbRcLsbRibRibRibRiLsbLibLjb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:22;Drug:CNO10microMApo0.5M
bLebRhbLoRsbLobLhRsbLgbLgbLsRsbLhLsbRcbLsLssbLjbLobRgbRhbRib

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:23;Drug:CNO10microMApo0.5M
bRibLibLjbReRssbLhbRhbLjLsLsssbRsbRcbLibLhbRhbRcbRibRibRib

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:24;Drug:CNO10microMApo0.5M
bRgbRgLsbLibRgbsbsbsbRibRiRssbRgbRsbLiLsbLibRsbLjbLjLssb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:25;Drug:ControlApo0.5M
bRgLsbRgRssbRsRssbLjbRobLiRsbLibRjRssb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:26;Drug:ControlApo0.5M
bLebLibLibLsLssb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:27;Drug:ControlApo0.5M
bRsbLhbRhbLibRhb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:28;Drug:ControlApo0.5M
bRibRcbRcbRgbLsbRgLsbRibRjRssbRgb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:29;Drug:ControlApo0.5M
bsbsbLsbRsLsbsbsbsbsbsbRsbsbsbsbsbsbsbLsbRsLsbLsbsbRsbsbRsRssbLsbRsbLsbLsbLsbRsbRsbsbLsbRsbRsbLsbsbRsbRsbLsLssbLsbRsbLsbsbRsRssbRsbsbLsLssbsbsbLsbsbRsbRsbsbRsbRsbsbsbLsbLsbsbsbRsbLsbRsbsbsbRsbLsbsbRsbRsbLsbsbsbsbsbsbRsbsbsbLsbRsbRsbLsRsbLsbLsbsbLibRjbRib

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:30;Drug:ControlApo0.5M
bRsbLgbLjbRebLcbRjbRcb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:31;Drug:CNO1microMApo0.5M
bRibRebLobLobLobLcbRibRebRgbLcbRebRebRebLebLgbRobLcbLebRgbRebLobLebLebRibRobRebLebLobRebRcbLsbRobLgbRobLgbRobRobRcbLebRsbRcbRobRcbLobLobRcbLgbRobLebLobRobLcbRgbRebRobRobRobRcbRobLcbLcbLebLobLebRobLobLgbLsbRibLcbLibLibRhbRcbLgbLobLgbRobRebLobRibLcbRobRgbLcbLobLebLibLibLobRibLobRgbRobRobRebLebRebLobRjbRobRsbRebLobLebLobRebLcbRobLebRcbLcbRibLcbRgbRebRobLobRibRobRcbRobLgbLobRcbRebRobLobRobRobLobLcbRcbLibRebRebRebLobRibRgbLobRobRobRobLobLebLcbRebLobLgbRibLcbRobLebLebLobLsbRhbRobRobRibRsbLebLibRgbLobLobLhbLobLobRhbRobRebLsbLobRcbLcbRcbLobRebRcbLebLcbRcbLobLjbLobRebRebLgbLobLobLobLobRcbRgbRobRebLibLobRobLobRebLcbLsbRcbRebLebRebRcbLibLgbLcbLobRsbRobLgbRcbRibLobLebRobLebRebRobRhbRibRebRobRebRcbRobLobLebLsbRobLobLcbLebLebLobLobLebLsbRobRibRgbRibRobRibRobLobLobLobRebRibLgbLobRebLebLobRhbLobLebRibLobLgbLibLobRobLcbRobLobRobRcbLebLobLcbRobLibRobLobRibLgbLcbLgbLibLobLobRebLobRobRibLebLobLcbLgbRobRobRebLcbRobLebLcbLsbLobRcbLcbLobLebLibLobLcbLebLebLgbRebLsbRgbRgbRebLhbRobRibRebRcbRsbLobRebLcbRobLobRsbRsbLobLebRebRobRcbRebLobRsbLebRebLcbRcbRobLobRobRobLobRebLobRobLhbLgbLibRcbRobRobRcbRcbLobLcbLebRebLcbLobLobLobRhbLobLcbLebLobLcbRobLibLobRobRsbLobRobLobLibRobLsbLobLobLobLobLobRebRibRibLobLsbLcbLebLcbLebRjbLebRhbRcbRibLobLcbRebLebLcbLgbLobRgbLcbLebLcbRibLobLobLebRobLebLibRobLgbRobLebRcbRibLobLcbRebLobLobRobLgbRsbLcbLobRobLobRobLebRebLcbLobRebRgbRibLsbRebLobLobLibRibRibLcbRhbRibLsbRcbLebRobRcbLcbLebLobLebLgbRcbLibRobLgbRebRobLcbLhbLobRebLcbRobRebLobRebLibRebRebLgbLibLebRobLibLobRebRebLobRhbRobRebRcbRobLgbLobLebLcbRebRobLcbLebRgbRgbRobRibLebLgbLobLcbRcbLebRcbLcbLebLobLebRobRibRobLobRsbRobLobLebRobRobLobRobRobRcbLobRgbRcbRcbRhbRobRsbRhbLebLcbLibRobRobLibRcbLhbLebRebLebLobRobRcbRebRobRobLibLobLjbLobRibLobLobRsbRibRgbLgbRcbRgbLobLgbRebLcbRgbLobLebRebRobLobLcbLobLebLobLobLhbLgbRgbRobRcbRsbLobRebRgbRcbLobLgbRcbLebRcbLebRcbRobRebLcbLgbRibLcbLobLebRgbRebRobLebLobRjbRhbRgbLobRobRobRjbLhbLebLebLsbRobLebRobRhbRobRsbLobLobLebRcbLebRobLobLebRobLobRebRebRobLgbRibLobRobLsbRgbRgbRibRcbRsbLgbLgbLebLgbLobLobRobRibLhbRobLobLebLebRcbLobLobLsbRibLcbRobLcbLobRcbRebRebRcbLcbRobLsbLebLgbRsbRebLjbLjbLobRebLjbLebRsbLjbLsbLsbLsbLsbRsbRobLebRebLobLebLobRobLobRobRcbRjbRjbRjbRjbLsbLobRjbLsbRjbLsbRsbRjbLebLsbRsbRsbLsbLobLsbLcbRobLebLebLobLjbLjbRcbRobLobRsbLebLjbRebLjbLjbRebRobRsbLsbRebRobLsbRsbRobRobLjbLobRibLebLobLobLobRjbLjbLebLjbLobRjbRgbLebLsbLjbLcbLobRebRobRobLcbRebLsbLcbLebLcbRgbLcbRibLobRebLebLobRcbRsbRobLebRobLebLsbLobRgbRobLjbRibLobLebRjbLibRcbRjbRobRebRobLobLebLobLgbRobRsbRebRobRebRsbRebLebRobLibLobRobLcbLgbRobLebLjbRebRobRobRjbLcbRjbLibRobRebRebRibRcbRcbRgbLobLebRebLobLobRebRcbLebLebRebRibLebLebLebRobLgbLebLcbLebRibRhbRcbLebRcbLebRcbLebRsbRibRebLobRebLobLsbRebLebRobLebRebLobLebLobRebLobLcbRjbRobLsbRibRibLobRgb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:32;Drug:CNO1microMApo0.5M
bRsbRsbRsbRgbRgbLgbLibRgbLibLsRsbLsLssb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:33;Drug:CNO1microMApo0.5M
bRiLsbRjRssbRhbRjbRsbLebLoLgbLsbRcbRcbLobLjbLoRsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:34;Drug:CNO1microMApo0.5M
bRgbLcb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:35;Drug:CNO1microMApo0.5M
bLoRsbLsLiLsLssbLsbRoRssbLhb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:36;Drug:CNO1microMApo0.5M
bLibRobLobRgRssbLibLsbRgbRgbLgbRgb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:37;Drug:CNO3microMApo0.5M
bRsbLsbRsbLobLeLsbRebRoLsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:38;Drug:CNO3microMApo0.5M
bLibLhbLobRiLsbLjbRgbRsbLsbLsbRgRsRsssbLgb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:39;Drug:CNO3microMApo0.5M
bLjbRcRsLiibLgRcLebRgLsbRgbLjbLibRgRssbRcLsbRcbRjRgbLcLssbRjb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:40;Drug:CNO3microMApo0.5M
bsbLgRsRhLsbLcbLiLsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:41;Drug:CNO3microMApo0.5M
bRiRssbLcbRsRssbRobRgbRsbRoRgRssbRsbLcbRjbRoRssbRebRsbRgbRjbRcbRjbRcbRjbRib

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:42;Drug:CNO3microMApo0.5M
bLcbLsbLobLobRebLcb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:43;Drug:CNO10microMApo0.5M
bRgRssb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:44;Drug:CNO10microMApo0.5M
bRgbLsbRsRgbRibRsbLibLobRgbRsbLcb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:45;Drug:CNO10microMApo0.5M
bRibRjbLhbLsLssbRibLsbLgLsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:46;Drug:CNO10microMApo0.5M
bLibRobsb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:47;Drug:CNO10microMApo0.5M
bLcLsRssbRcbLibsbRgb

>ZFRecording2016-03-21;tW:300s;Start:134734;End:135234;Recording:7-1;Individual:48;Drug:CNO10microMApo0.5M
bRgbRobRgbRcbRobLiRsbRibLiRsbRsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:1;Drug:ControlApo0.5M
bLgbLgbLsbLsbLgbRsbLsLgRsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:2;Drug:ControlApo0.5M
bRhbLibRibLibRibLgbLsbRsbRgbRsbRjRssbLjbLcbRjbRibLhbLibRsbRgRssbLibRcbRibRgbLibRjbRgRssbLhbLcbRgbRsbRgbLgbRsRgLjbRibRgbRsbLsbLcbLibRjRssb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:3;Drug:ControlApo0.5M
bLhbLebLjbLgbLjLssbRcbLobLcbLsRsRssbLjbRcbLibLgLsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:4;Drug:ControlApo0.5M
bRjRssbLibRgbRjbLoLssbLcbLcbLibRgb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:5;Drug:ControlApo0.5M
bReLsLssbRgbRgbRgbLsbLobRibLobLebRgLsbRsbLebRebRgbLsbLsbRobLsbRgbRgbLjbLcbLsLsLsLsLsLssssssb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:6;Drug:ControlApo0.5M
bRjbRsbRebLobLobRgbLebLcbLcbLebLsbRobLjbLjb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:7;Drug:CNO1microMApo0.5M
bRiRssbRcbLgbLiRsRssbLgbLgbLgbRcbLcRsbRhbLcb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:8;Drug:CNO1microMApo0.5M
bLjbRibLgbRibRibLjbRibLjbRsbLjbLjbRibLjbRjbLjbLjbRjbLjbLjbRibLebRjbLjbRjb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:9;Drug:CNO1microMApo0.5M
bLgbRjbRhbRibRhb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:10;Drug:CNO1microMApo0.5M
bLobRsbRoRjbLcbReRsLssbRibLsbRobLoLssbRcbRsbRibRjbLjbLcbLsRsbLibLobRobRob

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:11;Drug:CNO1microMApo0.5M
bRibRsbLsRsbLeb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:12;Drug:CNO1microMApo0.5M
bLebRobLcbRebRgbRgbLsbRgbRgb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:13;Drug:CNO3microMApo0.5M
bRibRsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:14;Drug:CNO3microMApo0.5M
bRgbLibLjbLcb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:15;Drug:CNO3microMApo0.5M
bLibLobRcbRoLsRsbRcbRobLjbLjbLibLibLibLibRiRssbLibRcbLsbRjbLjb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:16;Drug:CNO3microMApo0.5M
bsbLcbRcbRhbLibLcbLcbLcbLgbRibLcbLcbLgbLsbRsbLcbLgLsbLsbLsbLsbLsbLibRsLsbLcbRibLjbLibLhbRsbLcbLgbRibLsbLsbLibRobRibLcbLoRsbLibRibRibLhbRibRgbLsbLsbLibLgbRgbLhbRibLcbLibLhbLibLhbRgbRsRssbRgbLsRsbRgbRgbRjRsRsssbRsbRgbLebLgbRebLcbRjRssbLcLssbRjbRhbLhbRcbRcbRhbRcbRibRsbRcbRcbRgbRcbRhbRobRcbRcbRsbLsbLsbLsbLgbLgbRsbRjbRjbRgbLsbRgbRgbRobLhbLgbRgbRsbRsbRibRgbRsbRgbRgbLsbLjbLhbLgbLsbRibRgbRhLsbRibRcbRibRgbRgbRgbRgRssbLcbLibRebRcbRibRcbRcbRjbRgbRhbRgbRcb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:17;Drug:CNO3microMApo0.5M
bLobLibLhRsbRjRssbLjbLibLebLiLsbLgbLsbLibRhbLgbLcRsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:18;Drug:CNO3microMApo0.5M
bLcbRhbRgbLibRgbLgbRsbRibLsLssbRgbRgLsbRoLsbLiLsbLsbLiRsbLibLgbLgb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:19;Drug:CNO10microMApo0.5M
bRsbsbsbLsbRsbLsRsbsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:20;Drug:CNO10microMApo0.5M
bLjbLobLjbLcbRsRgbLsbLcbRhbLsRsbRobLsbLgRsbLiRsbLhbRcb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:21;Drug:CNO10microMApo0.5M
bLibRjbRibLebLgbRcbRhRssbRiLsbRibRibRibRiLsbRibLjbLhbRibsbLiRsbRcRssbRgb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:22;Drug:CNO10microMApo0.5M
bRhbLsbsbLsbRcbRibRgbLhbRjbLhbRibLcbRibRgbRgb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:23;Drug:CNO10microMApo0.5M
bRcbLgbLsLssbLhRsbRhbRcbRobRhLsbLsbLgbLcbLibLib

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:24;Drug:CNO10microMApo0.5M
bLsbLsbLibLsbsbLsbsbsbRsRssbLsbRsbRsbLsbLjbRjbRgRssbRgbsbLgbLjbLsbRsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:25;Drug:ControlApo0.5M
bRgbLsLssb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:26;Drug:ControlApo0.5M
bRsLsbLgbLgbRcbRhbRjbLjbRjbRebRjbRcbRhbRjRiLsbRebLhLsbLibLibRibRjbRcbRgbRibRcbRgbLibLsbLibRsbLsbLibLobRgbRjbRjbLjbLcbRgbRjbRcbRgbRibRsbRibRsbLsbRjbLjbRjbRjbRjbRibRgbRjbLhbRoRsLssbRhbLsLssb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:27;Drug:ControlApo0.5M
bRibLgRsbLgbLsbRgbRibRjRssbRjb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:28;Drug:ControlApo0.5M
bRibLib

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:29;Drug:ControlApo0.5M
bLgLsbRsbRcbRibRjbLgbLsbRsbLsbLsLssbLsbLsbRcbRgbLsbRibRgbLgbRgbLsbLsbRgbLsbLsbRsRssbRgbLgbLjbLibLgbLgbLgbRsbLjbLgbLgbLgbLsbLgbLsbLgbLgbRsbLsLssbLgbRsbLgbRsbLjbLgbLgbLsbRsbLsbRsbLsbLgbLsbLsbLsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:30;Drug:ControlApo0.5M
bRsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:31;Drug:CNO1microMApo0.5M
bLhRsbRiLsbLjbRgbLjbLobRibRsRjbRgRsLssbRcbLibLsbRsbLsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:32;Drug:CNO1microMApo0.5M
bRsbLiLsbRsRssbLsLgbRgbRibLjbLibLsLssbRibLhbRgbLobRobRgb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:33;Drug:CNO1microMApo0.5M
bRobLeRsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:34;Drug:CNO1microMApo0.5M
bRsbLsbRobReLsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:35;Drug:CNO1microMApo0.5M
bRsRsRsRsRsssssbRgbRsRssbRgbLibRibRsbRsbLsbLsbLjbLjbRjbLhbRgbLsbLsbLibReRssbLjLgbLgbLib

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:36;Drug:CNO1microMApo0.5M
bLibRsbRgbLibRibLhbRgLsbRgbRhbRgRssbLib

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:37;Drug:CNO3microMApo0.5M
bLjb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:38;Drug:CNO3microMApo0.5M
bRsbsbLob

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:39;Drug:CNO3microMApo0.5M
bLhbRibLcbRobRobLgbRibLhLsbRcb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:40;Drug:CNO3microMApo0.5M
bRcbLibLib

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:41;Drug:CNO3microMApo0.5M
bRjRsRsssbLobRsbLibLsbLjbRcbRobRcbRcbLcbRjbRjbRcbRcbRsbRgbRgbLcb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:42;Drug:CNO3microMApo0.5M
bLcbLsbRibLobLibLjbLobLcbLiLsbLibRgbLgLsLssbRhbLcbLcbLobLcLssbLgbLsbRsRssbRsbLhbLcbRcbRcbLcbLcRsbRibRibRobRobRhbRcbLsbLsbLiLsbLgbLsbLsbLsbLgRsbLsbRsbLsbLgbRjbRsRobRibRibLsbRgbRgbLsbLsbRibRibLsRsbRsbLsbRoLsbRcLsbLsbLsbRsbRibRobRibLgbLhbLibLjbRibLjbRjbLiLsbRsbRgbLsLcbLjbRcbLibRsbLcbLiRsbRsbLhb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:43;Drug:CNO10microMApo0.5M
bRgbRsbLobRsbLebReLsLssbRcbLebRhbRibRcLsbLgbRibRjbLgLsbLhLsRsbRcb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:44;Drug:CNO10microMApo0.5M
bRsRsRsssbRgLsbRgbLsbLsbRsb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:45;Drug:CNO10microMApo0.5M
bLsbLgbRsbLjbLibRoLsbLgbLib

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:46;Drug:CNO10microMApo0.5M
bRobLgbLgb

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:47;Drug:CNO10microMApo0.5M
bRjbLgbRibRsbLgbLcRsbRcLsbRobRcRssbRib

>ZFRecording2016-03-21;tW:300s;Start:135236;End:135736;Recording:8-1;Individual:48;Drug:CNO10microMApo0.5M
bLeLsbRobRcbRcRssbLjb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:1;Drug:ControlApo0.5M
bRsbsbLgbsbsbRsbLsbsbsbsbsbsbsbsbsbsbsbsbRsbsbLsbLsbsbLsbsbsbsbRgbRsbRcbLobRcbLobRebLgbLobLjbRebLsRsbsbLsLssbLsbsbLsbRsbLsRsbRsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:2;Drug:ControlApo0.5M
bRhbLjb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:3;Drug:ControlApo0.5M
bRjbRobLebLobLgbLhbRcbLcRsbRibLobLhbLibLcbRebLibRiLsbLcbRsLcbLcbRcbRebLsbLsbRebLiLsbLebRsRobRibLjbLjbRebLibLgbLgbRhb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:4;Drug:ControlApo0.5M
bLsLsLsssbRibRcbRibLobRobRjbRibLcb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:5;Drug:ControlApo0.5M
bRcbLsbRjbLibRibRjbLgbLjbLebRibRobLcLssbRibLjb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:6;Drug:ControlApo0.5M
bRgbRsbLjbRsbLsbRsbLebRsbLibLibRcbRgbReb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:7;Drug:CNO1microMApo0.5M
bRsbRcbRsbRhbRsLsLsRsLsLsssbLgbRcbLibLcbRibLibRhLsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:8;Drug:CNO1microMApo0.5M
bLcbLjbLiRsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:9;Drug:CNO1microMApo0.5M
bLibLcbRobLobRcbRibRhbLcLssbRcbLgbLgb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:10;Drug:CNO1microMApo0.5M
bLoLsLsssbLjbLjbLjbRsbLeRsbRgbLiRsbLcbRebLebLcbLjbLobLcbLoLssbLsRsbRebRgLsbLsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:11;Drug:CNO1microMApo0.5M
bLib

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:12;Drug:CNO1microMApo0.5M
bLsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:13;Drug:CNO3microMApo0.5M
bLjbRsbRsbRgb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:14;Drug:CNO3microMApo0.5M
bRjbLcbRibRhbLjbRibLcRsRssbRsbLibLcbRgbRcbRcbRibRsbRib

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:15;Drug:CNO3microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:16;Drug:CNO3microMApo0.5M
bRhbRjbRhbRibRhRssbRibRsbLgbsbRsbRsbRibRsbRebLcbLcbLcbLcbLibLgbLsbLib

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:17;Drug:CNO3microMApo0.5M
bLsRsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:18;Drug:CNO3microMApo0.5M
bRhbLibLiRsbRgbLgbRjbLgbLgbLsbRgbRjbRibLibRgbRoRssbLcRsRssbRgbRgbLgbRibRgb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:19;Drug:CNO10microMApo0.5M
bRgbRcbRjbRjbRcbLjbReb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:20;Drug:CNO10microMApo0.5M
bRsLsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:21;Drug:CNO10microMApo0.5M
bRibRcbRibRibLgLsbRjb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:22;Drug:CNO10microMApo0.5M
bLiLsbRib

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:23;Drug:CNO10microMApo0.5M
bLibLiLsbRcRssbLsbLibLgbLoRsbRobLgbLsbReRsLssbRibLgbRibRebRobRibRhbRibRiRssbRcbRibLgbRcbRib

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:24;Drug:CNO10microMApo0.5M
bLgbRcRssbRsbRsRssbRsRssbRsbRibLgbsbLiRsbRgbsbsbsbsbsbsbsbRibLsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:25;Drug:ControlApo0.5M
bLsbLcRsRssbLjLssb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:26;Drug:ControlApo0.5M
bRsbLcbLcLibRgbRsbRibRgb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:27;Drug:ControlApo0.5M
bRjRssbRibLobRibLsbRiRssb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:28;Drug:ControlApo0.5M
bRebLcbLsbLsRsLsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:29;Drug:ControlApo0.5M
bLgbLsbLsbLgbLjbRcbLibLibLsbRsbRgRssbLsbRgbRgLsbRjbRibRsbRjbLsbsbRjbLgbLjbLjLssbLibLgbLgbLgbRgbLsbLsLssbRgbLsbRjRssbLgbLsbLgbLsbRgbLgbRjbLgbLgbLgbLgbRsbRjbRcbRjbLjbLjLjbLibLjRsbLgbLjRsbLgbLsbRsbRsbLsbRibRjbLibRjb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:30;Drug:ControlApo0.5M
bLibLhbLhb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:31;Drug:CNO1microMApo0.5M
bRjbRebRcbLgbLsRsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:32;Drug:CNO1microMApo0.5M
bRiLsbLcbRgbRsbLgbRgbRgbRgbRibRgbLiLsbLib

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:33;Drug:CNO1microMApo0.5M
bRobRoRssbRhbLibRcbRcbRebRjbRobLcbLgbRsbLsbLibLibLibLibLibLsbLsbRsbLjbLjRsRssbRsbRjbLhbLebLibRgbLjbLibRibRhbLjbLjbLjLssbLibLcbLhbLsbLcbLibLibRibRcbRcbRjbRobRjbRjbRsRibLjbLcbRjbRcbRibLibLsbRobLibLsRsbLjbLjbLeLsbRgbRibRhbRibRebLjbLjbLsbLsLsLsssbLsbRjbLjbLobLibRcbRibRjbRibLibRibLibLcbLibRsbRgbLsbLsbRsbLsbRjbRibRsbRsbRsbRgbRsbRjRssbLjLssbLibsbLcbRgbLjLssbRjbRgbLcbLibLibRibRjbRsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:34;Drug:CNO1microMApo0.5M
bLgb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:35;Drug:CNO1microMApo0.5M
bLjLgLsbLgbLib

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:36;Drug:CNO1microMApo0.5M
bRiRssbLibLibRibLebRsbLibRgbRgbLibRgbLcb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:37;Drug:CNO3microMApo0.5M
bRjbRebRebRcbRebRjbRibRebRobLcbLjbRobLobRcbLsbLcbLcbLibRobLebLobRobLobRjbLobLjbRsbLebRobLjbRebRjbLobLobRjbLjbRjbLcbLebLcbRsbLsbLcbRobLobLibLcbLobRebLebRsbRebLcbRcbLjbRcbRibRebLjbLobRobRsbLjbLsbLebLcbLobLobLobLobRjbRjbLcbLobLcbRjbLjbLobLobRebRobLobLsbRgbRgbLibRsbLebLcbLcbLibLobRebLjbLcbLcbLobLgbRobLebLibRcbLcbLobLobRobRobRebLibRobRgbRgbRebRobLobLobLobLibRsbLobLobRebRcbLcbLobRobLcbRebLebLobLsbRcbLobRcbRobRsbLobRobLcbRebLebRcbLcbLcbRsbRjbLobRebLobLibLobRhbRsbRebRobLebLobRobRebRebRibLebLhbLobRebLobLcbLobLgbRobRobRobRobLebLcbLobRebLcbLobRebRcbRobLobLobRcbRebLcbLobRebLobLobRobRobLobLsbRebRibLsbRobLebLobLobRgbRobRgbLcbRcbLobRibLebLgbLhbRobLebRgbRcbLcbLebRcbLobLobLcbLobLebRobRobLobLobLcbRebRcbLebLobLsbLcbLcbRcbRibLobRebLsbRobRobLobLebRobRobLobLobRobLobLebLebLebRgbLebLobLebLsbLgbRcbRhbRibLobLobLhbLebLibRcbLobRobRobRebLobLibLobRobRobRobRobRobLhbRobRgbRobLibLcbRobLobRobLebLobRobLibLobRobRhbLobLobRcbRobLebLsbRibRgbRobLobRibRcbRobRebRobRcbLibLobLcbLobRcbRebRebLobLsbRobRhbLobLsbLhbLcbLsbLobRgbRobLobRobRcbLsbLcbRebLcbRobLebLobRobRobRibLcbRobLebRobRcbLsbLibLebRhbLcbLgbLebLsbLobRibLebRobRgbLebLebRgbLobLebLobRobRobRcbRebRebLcbRobLobLcbRobRgbRobRcbLobLcbRibRebLobRcbLsbRebLobRobRobLobRebLcbLgbRobRsbRebRobRobRobRebLobRcbRcbLobRebLobLcbRobRcbLsbLobLebLjbLobRsbRcbRobRobLobRobLobLobLjbLebRcbRsbRjbRsbRsbRsbLcbLobRobLebRobLgbLjbLjbRebLebLsbRcbLebRobLcbRjbRgbRobLjbRebRcbRebRjbRgbLobLibRebLcbLobRobLobRcbLobLsbRobLebRobRebRjbLcbRcbLebLobRobRebLcbLcbLcbLebLobRobLcbLobRobRcbLjbLebRobLobRobRebLebRcbLsbRcbRsbLcbRjbLebRobLibRcbRebLobRcbRobLebRcbRobRobLebRjbRebRcbLibLobRjbLobLebLjbLobRebRjbRobRebRobRjbRjbLebRobRobLobRjbRjbRobRcbLibLobLjbLgbLjbLobRjbRgbLcbRgbLjbLjbRebRebRcbRebRebRebLobLebRobLsbLcbRcbLebRjbLcbLobRebRjbLebLcbLcbRebRcbLsbLebLebRibRobRebRobRobLobRobLebRobLobRobRebLobLebLsbLobLcbLcbRebLobRjbRobLgbRebRobLobRcbLobRcbLebRebRobLcbLobLgbRjbRobRobRsbLebLcbLobRjbRcbRobRobRgbLcbRibLebLibRobLobLobRhbRebRhbLobRebLobLebLebRcbRsbLcbRobLobRebRebRobLebRsbRcbRobLcbRobLobRebLobRcbLobRobLsbRibRjbLebLcbRcbRcbLobRcbLebLobRebLobLgbLebLobLcbLobLobRobRebLobLobLcbRobLhbRhbLobLobLcbRibRibRobLobRebRobRobLgbLobRobRsbLebLsbRcbRcbRobLgbRobLobLebRobRcbRgbLjbLsbLibRobLobRobRebLebRobLobRobRibLcbRgbLebLebLobRsbRebRgbLobLebLobRjbLsbLgbLobRcbLjbLsbRjbRjbRcbLjbLebRobRobRobLobLobLcbLebLobLobLobRjbRobRebLebLobRobRobRebRjbLobRibLebRobRcbLobRebRjbLebLobLobLjbRobLcbRjbRsbRjbLsbRebRobLcbRebLsbLgbLjbRsbLebRcbRebRsbRobRobLsbLcbLobLobRcbRobRjbLobRebLobLobRgbRjbRcbRcbRobRsbLobRobRjbLhbLcbRjbRobLcbRsbLobRobRgbLsbLsbLjbLobRcbLobLjbRjbRjbLobLobLobRebRebRjbRobRobLobRobRgbLebLobLsbRcbLobLebRebLebRobLsbLsbRebRobLjbRebLsbRebRjbRsbLjbRjbLobRobRcbLobLobRobLobRobLobLsbRobRobRobRebLobLcbRsbRjbLobRcbRebLobRebLjb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:38;Drug:CNO3microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:39;Drug:CNO3microMApo0.5M
bLhLsbRjbLobLobLiRsbLobRjbLibLsbLibLcbRibLjbLibLibLsbLgbLgbLhbLgbLsbLibLsbLibLgbRsbRsbLibLibRobRibLibRibLjLssbRobLibLgbRibLibLibLcbRgbLibRgbLgbLsbLsbLsLgbLgbLobLibRibRibRsbLsbRgbRibLgbRibLgbRgbRgbRgbRgbRibRibRgRssbLsbRgbLgbRibLgbRibRcbLgLsbLsbLgbLgRsbLgbLibRsbLsbLgbRsbLsbLgbLsbRobLhbRobRcbLgbRsbRsbLsRsLsbLsbRgbRjbLcbLhbLhbRgbLgbLgbLsbLsbLgbLiRsbLibLgbLgbLgbRibLjbLibRhbRobLcbLgbRsbLibLibLsLssbLgbLsbRsbLgbLgbLgbRibRsbLibRsbLibLgbLgbRgbRgbLjbLgbRoLsbRcbLhbRibLibRiLsbLibRibRibRibLsbLgbLsbLgbLcbLcbRhbLcb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:40;Drug:CNO3microMApo0.5M
bRobLjLebRoLsbLgbLgLsbLgbRob

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:41;Drug:CNO3microMApo0.5M
bRcbLcRsbLoLsLsssbLsbLsbRobRcRssbLsbLsbLjbLobRhb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:42;Drug:CNO3microMApo0.5M
bLsbRobLibLsbLsbRhbLjbRcbRoLsbRgbLibLobLsbLsbRiLsbRgbRgbLjbRibRiRssbRgbRsbRgLsLssbRgbRsLsbRgbLsbLsbRjbRsLcbLcbLjbLgbLsbLgbLsRsbLsbLsbLgbLgbLsbRiLgbRgbLjbRobRibRgbLsbRebLjbRobRcbRsbLebLcbLjbLibRib

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:43;Drug:CNO10microMApo0.5M
bLgbLgbRcRssbRibLcbRjbRebRebRjRssb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:44;Drug:CNO10microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:45;Drug:CNO10microMApo0.5M
bLibsbLjLssbRob

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:46;Drug:CNO10microMApo0.5M
bLib

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:47;Drug:CNO10microMApo0.5M
bsb

>ZFRecording2016-03-21;tW:300s;Start:135738;End:140238;Recording:9-1;Individual:48;Drug:CNO10microMApo0.5M
bRjRssbRoRssbRibRibRcbRjbRcbRibRibRcbRjbRjbRcbRhbRjbRibRibRjbRibRhbRjbLjbLjbRgbLjb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:1;Drug:ControlApo0.5M
bLoRsbRobRibLgbLsbLsbLsbRsbLsLssbLsRsbLgbLgbLsbLgbLobRiRssbLcbRibRjbLsbRhbLsbRibLgbLsbLhbRcbRgbLsbLsLssbLsbRsbLcbRsbLhLsbRhbRsbLgbLjbRibRibLcbLcRsbRcbLibRcbLgbRsbLsbLgbLsbRsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:2;Drug:ControlApo0.5M
bRsbLibRsbLiLsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:3;Drug:ControlApo0.5M
bLgbRebLgRsbLebRgRssbRcbLibLgbRobLgLsbRsbLgbLgbRebLobLsbRsbRgbRib

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:4;Drug:ControlApo0.5M
bRobRhRssbRobLsLssbLibLgbRibRibRjbRibLcbRiLsbRsbLgbRcbRibRsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:5;Drug:ControlApo0.5M
bLibRcbRiLsbLjbRgbLgbRgbLsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:6;Drug:ControlApo0.5M
bLsbLhb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:7;Drug:CNO1microMApo0.5M
bLibRibLgbLsLsLgLsLgLssbRiRssbLsLsLgLsLsLiiibLhbLcbLgRsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:8;Drug:CNO1microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:9;Drug:CNO1microMApo0.5M
bRjRssbLibRibLibRibLibLsbRcb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:10;Drug:CNO1microMApo0.5M
bLgbLebLsLssbLcbLgLsbLsbLgbLobLibLibLobLsbLcbRjbRob

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:11;Drug:CNO1microMApo0.5M
bLsbLibRhbLjbLcbLcbLgbLobRgbRsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:12;Drug:CNO1microMApo0.5M
bRibRcbLcbRibRgbRsbRgb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:13;Drug:CNO3microMApo0.5M
bLiLsbRjbLhbRsLsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:14;Drug:CNO3microMApo0.5M
bRcbLiRsbLgbLsbLsbLibLgb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:15;Drug:CNO3microMApo0.5M
bLoRsbRobRobLob

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:16;Drug:CNO3microMApo0.5M
bLeLsbLcbLcbLgbLibRcbRhbRibRibRibLgLsbLgbRcbRsbLcLssbLcbLsbLcbRibRsbRsbLsbLsbLiRsLsbRsRssbRgbRgbReRssbRgbLgbRiRssbRjRssb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:17;Drug:CNO3microMApo0.5M
bLgbLibLsbLsbLjbLibRgRssbRhb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:18;Drug:CNO3microMApo0.5M
bLcbLjbLibLcRsRsLssbRiRssbLsbRgbRibLgLsbRsbRsRsLssbLgbRgb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:19;Drug:CNO10microMApo0.5M
bRgbRjb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:20;Drug:CNO10microMApo0.5M
bLebRcLsbRhRssbRcbRobLcbLcbLjbLcbLsLssbRobLsLsLsssbLsLssbLsLssbLib

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:21;Drug:CNO10microMApo0.5M
bLib

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:22;Drug:CNO10microMApo0.5M
bLcRsbRobRobLjbLiRsbLibLjbLjbRoRssbLjbLibRibRiRssbLob

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:23;Drug:CNO10microMApo0.5M
bRcbLobLgbRjbRjbRibRibRgbRibRibRibLhbRcbRebRsbRibRgbRgbRgbRibLsbLsbLsbLsRsbRibLjRsbLsbLibRcbLjbRibLgbRgbRgbLhbRibLebRibRiRssbRcbLib

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:24;Drug:CNO10microMApo0.5M
bLibsbsbsbsbsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:25;Drug:ControlApo0.5M
bLgLsRsbLobRgbRsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:26;Drug:ControlApo0.5M
bRoRssbRhbRhb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:27;Drug:ControlApo0.5M
bLgbLebLeLsbLsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:28;Drug:ControlApo0.5M
bRsbRcbRcbLibRsLsRsbRjbLgbRgbRsbRsRssbLjRsbRcbLibLibLibRsbRgbRibRobRoLsbLibRobLgbLsbLibLgbLsLibLibRibRsbLgbRsbRgbLgbLgbRsbLibRibLiLsbLgLgbLsLssbRobRibLobRibLgbLibLibLgbRsbLgbLjbRibLcbRhRgbLoLssbReRssbLobRcbRibLcbRjbRgbRgbRjbRibLsbRsLsbRsbRsbRgbRsbRgbRgbRiLsbRcbLgbRibLsbLgbLibLibRgbLgLsbRsbRibRgbRgbRibLgLsbLgbLibRjbLgb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:29;Drug:ControlApo0.5M
bRjbRcbsbsbRjbRgbRiLsbRgLsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:30;Drug:ControlApo0.5M
bLibRsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:31;Drug:CNO1microMApo0.5M
bRjbRebRsbLsbRobRjbRjbRsbRebRgbLobLsbLsbLobLobLcbRibLgb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:32;Drug:CNO1microMApo0.5M
bRgbRiLsbLsLssbLcbLibLcbRhbRibLjbLebLibLsbLcbRsRssbRibRgbLgLsbLebRgb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:33;Drug:CNO1microMApo0.5M
bRjbRsRibLjLssbRibRjbRiLsbLibRibLjLssbLjbLhbRgbLgbLibLjbLcRsbLjbLibRibLsbRibRgbLibRgbRibRgbRgbLsbRsbLsbLgRsbRsbRjbRibLibLgbRgbRgbRjRssbLgbLsbLsbLsbLsbLgbRibLgbLgbRhbLsbLgbLjLssbRebRsRjbLjbLibRjbRobRjbRhbLjbRsbLjbRibRsRsRsssbLibLiLsRsbLgbLgbLhbLiRsLsbRgbRsbRsbLjbLjbLhRsbLgLsRsbRsbLsbLgbLgbLgbLgLsbLsbLsbLibLjbLjbLhbRibRibLjbLcbRjbRjbRhbRjRssbLiLsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:34;Drug:CNO1microMApo0.5M
bLcRsbLib

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:35;Drug:CNO1microMApo0.5M
bLibsbLsbRsbRjLsRsbRsbLsRsbLjbRoLsbLjbLjb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:36;Drug:CNO1microMApo0.5M
bLjbsbLsbLibLibRibLiRsbRgbLjbRcRsRsssbRgbLib

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:37;Drug:CNO3microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:38;Drug:CNO3microMApo0.5M
bLsLssbRibLibRsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:39;Drug:CNO3microMApo0.5M
bRjbLsRhb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:40;Drug:CNO3microMApo0.5M
bRcbRcbRibRjbRiRssbRjbLjbLjbLjbLcbRjbRcbLjbLjbRibLcLssbRjbRcbLsLobRgbRgRssbRgbRsbRgbRgbLsbLsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:41;Drug:CNO3microMApo0.5M
bRsbLgbLsbLsbLhLsRsbRobRsbRsbRjbRcbRcLsbLobLcbRjbLebLjbRjbRhRssbLjbRib

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:42;Drug:CNO3microMApo0.5M
bLjbRib

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:43;Drug:CNO10microMApo0.5M
bsbRsbLibLsbLgbLgb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:44;Drug:CNO10microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:45;Drug:CNO10microMApo0.5M
bLjbLiLsb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:46;Drug:CNO10microMApo0.5M
bRsLsRsbLsbRsbLsbsbRsLsbRsbsbLsbLsbsbLob

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:47;Drug:CNO10microMApo0.5M
bLsLssb

>ZFRecording2016-03-21;tW:300s;Start:140240;End:140740;Recording:10-1;Individual:48;Drug:CNO10microMApo0.5M
bLoRsbRjbLhbLcbRsbRibRjbRhbRobRibRjbRsLiLsLgLsRsbRoLsLsRssbRcLsbRjbRhbRsbRibRsbLcbRiRssbRjb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:1;Drug:ControlApo0.5M
bRobLcbLcRsbRgbRjbLoRsbRgbLsbLsbLobLib

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:2;Drug:ControlApo0.5M
bRibLgbRsbLjbLjbRjbLcbLsbRcbLeLsbRjb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:3;Drug:ControlApo0.5M
bLsLiLsbRcbRgLsRsbLobRsbLoLsLsssbLsbRsbRgbLcbRgbRsbRhbRobRhbLjLgbLjbLibRsbRgbRsbLcbLibLibLibLjbRhbLcbLjRsbRhbLsbLsbLoLssbLgbRcbRobLjbRibRsbRgbRgbLebRibRibRjbRgLgbRgbLgbLobRsbsbLsbLsbRjbRibLjbRsbLhbLjbLsbLgbRcbRebLsbRsbRobLcbLsbLibLjbRhbLibLgbRibRsbRhbLibRcbLiRsbRcbLcbRjbRobRsbLcbLjbLibLibLiRsbRsLsbLgbRsbLsbLibRsbRsb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:4;Drug:ControlApo0.5M
bLibRibRhb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:5;Drug:ControlApo0.5M
bRebRgRssbLgbLjbRgbLibLjbLibLsLgbLgbLjbLib

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:6;Drug:ControlApo0.5M
bRgbLcRsbLebRsRsLssbRcbRibRiLsbLsbLsLssbLsLgbRgbRiLsRsbLgbLjbRebRjbRebLobLobRebRobLebRgbLibLobRebRjbRebRjbRobRjbLobRcbLibRcRssbRjb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:7;Drug:CNO1microMApo0.5M
bLibRjbRibLibRjRgbLsbLgbRcbLibRhbLjRsbRebLcRsb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:8;Drug:CNO1microMApo0.5M
bLjb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:9;Drug:CNO1microMApo0.5M
bLibLhbRobLsbRsbLobLibRobLcbRobLiLsbLibRsbRiRssbLhb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:10;Drug:CNO1microMApo0.5M
bLcbLhbLcLssbLibLcRsbLgbRgbLjLssbRobRebLgbRibLibLjbReRssb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:11;Drug:CNO1microMApo0.5M
bRcbLibRhRssbLcbLgb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:12;Drug:CNO1microMApo0.5M
bRjbRsb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:13;Drug:CNO3microMApo0.5M
bRsRssbLsbRsbLsbsbLsbLsLssbRsbRsbLsbsbsbsbsbsbLsbsbLsbsbsbsbsbRjbRsbRjbLjb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:14;Drug:CNO3microMApo0.5M
bRjRjbRibRgbLhbLebLsbLgbRjRssbRjb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:15;Drug:CNO3microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:16;Drug:CNO3microMApo0.5M
bLcbLebRebLeb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:17;Drug:CNO3microMApo0.5M
bLibRcRssbLcRsbReLsbLgLsbRcbLgLsb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:18;Drug:CNO3microMApo0.5M
bRjbLsbsbLobRibLgbLgbLsbRsbLgbLibLgbLobLsbRjRssbRsbRgbRibLsbLgb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:19;Drug:CNO10microMApo0.5M
bLgbRjbLjbLgbRhbRjbRhbRibRibRsbRiRssbRgRssbRsbRsbRibLsbRsbRobRgbRibRibRgLsbRibRgbLsbRibRibRgbLobLgbRsbLibRgLibRib

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:20;Drug:CNO10microMApo0.5M
bRjbLibLobLjbLiRsRssbLjb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:21;Drug:CNO10microMApo0.5M
bLhbRgb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:22;Drug:CNO10microMApo0.5M
bRobLsRsbLcLssbRiRssbRibLsbLobLsbRgbRgLsRsbRsbRsbRibRsbLobRcb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:23;Drug:CNO10microMApo0.5M
bRibRhRssbLhbRhLsbRebLhbRjbRibLgbLsbLgLsLssbRibRcbRhLsbRcbRibRib

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:24;Drug:CNO10microMApo0.5M
bRsbRgbRgRsLssbsbsbLsbsbRsbLsbLgbRgRssbLsRsbRiRssbLsbRgbRobLgLsbLibRsbRcbLjbLjbRjbLgbLsbRsbRsbsbsbsbLsbLsbLsLssbRjbRcLsbRibRgbRgbLsbRsbRgbLjbRiLsbRibRibRgbLjbRobLsbRiLsbLjbRgbRsLsbRibRibRibLgbRsbRgLsbLgbRibRsbRsRssbRsbRsbRgbRhbRjRssbLiRsbRsbRgbRibRcbLsbRibRsbRsbRgbRsLsbRgbRhbLgbRjRssbRibLgRsbRgbRsbLsbLjbRjbRjRgbRibLsRsbRsbRgbRiLsbLjbRiLsbLgbRgbRiLsbLiRsbRsbRgbLgbRgbRgbRgbRibRgbRibRjRssbRsbRgbRsRssbRsRjbLsbRgbLgLsbRiLiLsbRjRssbRcRssbLibRsbRgbLsbRgbRibLjbRjbLibRjbRjLsbLgbRjbRgRssbLsLgb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:25;Drug:ControlApo0.5M
bRsRssbLsLsLsLssssbRsbRgbLobRsbRgRssbRsbRsRsRsRssssb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:26;Drug:ControlApo0.5M
bsbLsRsbsbsbsbsbLjb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:27;Drug:ControlApo0.5M
bRsbLgbRjbLib

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:28;Drug:ControlApo0.5M
bRhbLjbLibRgbLibRsbLibRibRibRgbLjbLibRjbLsRjbRhbRgbRsbRsbRibRgRgbRhbRibRsbRgbRgbRgbRgbRibRjbRcbLibLibLjbLjRsbLgRsRssbRjb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:29;Drug:ControlApo0.5M
bRgbRibRhb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:30;Drug:ControlApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:31;Drug:CNO1microMApo0.5M
bLibRjbRjb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:32;Drug:CNO1microMApo0.5M
bRgbRgbRibLobRjbLcLssbRjRssbLgLsLssbRgb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:33;Drug:CNO1microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:34;Drug:CNO1microMApo0.5M
bLgbRibRsbRsbLobLcb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:35;Drug:CNO1microMApo0.5M
bLsbLgbLgbRgbLsbLgLsb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:36;Drug:CNO1microMApo0.5M
bLgbRebRobRsbsbRgbLgbLgbRsbRgbLgLsb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:37;Drug:CNO3microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:38;Drug:CNO3microMApo0.5M
bRsRssbLjb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:39;Drug:CNO3microMApo0.5M
bRgLgLgb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:40;Drug:CNO3microMApo0.5M
bRibLjbLjLssbLibLsLib

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:41;Drug:CNO3microMApo0.5M
bLcLsRssbRcbRcbLoRsbRjRssbRcb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:42;Drug:CNO3microMApo0.5M
bLhLsbRgbRjbLhbRcbLgbLsb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:43;Drug:CNO10microMApo0.5M
bRjbRcbRebLebRobRebRjbRebLebRcbLjbRobRjbLebRebRjbLobRebRobLobRobLobRjbRobRobRebRebLebLobLobLjbRobRjbLebLebLjbRjbLcbRobLobLobRcbLobRebRobRobRsbRobRobRjbRcbLobLobLobLcbRibLobLobLjbLcbRjbRobLobLjbRobLobRobRjbLebRobRobLebLobLobRjbRobRobRebLjbRobLobRcbLobLobLibLcbRsbLcbLobRjbLebRcbRibRjbRcbLjbRobRobLobLjbRobRsbLgbRjbLsbLjbRobLjbRcbLobLjbRobRobRgbLobRjbRjbRobRebRobRobLobLobRcbLobLjbLobLobRcbLjbRjbLcbLobLebRjbRebLcbRobLobLcbLjbRcbRjbLobLcbLebLebLobRebRcbLobLebLobLjbLsbLjbRobRobLobRobRcbRcbRebRebRjbRobRobRobRebRobRcbLjbLobRcbRgbRebRebRobLobRobLjbLobRebRjbRobRjbLobLjbLebRsbLjbRsbLebRsbLcbLcbRjbRjbRobLobLcbRebLobRebLgbRobRjbRebLcbRsbRjbLjbLcbRobLebRjbLcbRobRjbLcbLebRjbRjbRjbRebLobRebRebRcbRebRjbRcbRobRobRjbRobRebRjbLebRjbRobRjbLcbLobLcbLcbRjbRobRebRobLjbRobLcbLobLcbRebRobRebRebLobRjbLobLjbRjbRebLjbLjbRebRjbLebLobLebLcbLibLebRobRobRobRobLobLjbRobRsbRsbRsbRobRcbLcbLebLebLebRjbLcbRsbLjbLobLcbLjbLobRcbLebRjbLobRsbLobLjbRjbRebRjbLobRobLjbRsbRobLobLebRobLjbLobLcbLebRjbRebLobLebRjbLjbLcbRjbRebRebLobLebRjbRobRhbLjbLjbLjbRobLobRebLjbRebRjbRobLjbRobLsbLebLobLjbLebLcbLobRebLobLobRebLebRjbLobLobLebRjbRjbLsbLobRobLobLebRcbRebLobLjbLobLebRjbRebLobRobRjbLjbRob

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:44;Drug:CNO10microMApo0.5M
bRgbLsRibRsRssbRsRssbRsbRsbLsbLsbLgbRsbLcbLgbRsbRsbLsb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:45;Drug:CNO10microMApo0.5M
bRibLhLsbRibLsLgbRibRhbRgbLoRsbRcbRgbRsbRibRibRhbLgbLibRcbRibRsbRibRibRgbRsbRgbRgbRibRcbLsbRcbRcbLsLgbRibRgbRobRiLsbRsbRsbLcbRibLibLibLibLgbRgLsbLibRibRcbLjLibLibLsLssbLgbLsbLobRsbRgbLcbLcbLgbRgbLsLssbRsbRjbLhbRibLjbLsLibLobLibLgLsRsbRcbRibLgbLcbLibLsbLgbLsLssbLgbLsbLgbLsLgbLibRgbLibLgbLsbLgbLsbLsLgbLgbLgbLsLsLsssbLgbRsbLgbLsRsbLgbLsbLsbLgbLgbLsbLsLssbLsbLgbLsbLgRsbLgbLgbLsLssbLgLsbLgbLgbLgbLsbLibRgbRsbLgbLgbLgbLsRsbLgbLgbRsbLgLsbLsbLgLsbLsbLgbLgbLgbLgbLsbLgbLsbLgbLsbLsbLibRebLibLibLgbLsb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:46;Drug:CNO10microMApo0.5M
bLibLsLgb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:47;Drug:CNO10microMApo0.5M
bLjbRsbRsbLsRsbLibRcbRcLsbLsb

>ZFRecording2016-03-21;tW:300s;Start:140741;End:141241;Recording:11-1;Individual:48;Drug:CNO10microMApo0.5M
bLibRsLsbLibRcbRhbRgbLcbLibRgbLibRsbRsbLibLibLgbLhbLgbRibRjbRjbLob

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:1;Drug:ControlApo0.5M
bLiRsbLobRgb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:2;Drug:ControlApo0.5M
bLoRsbLibRjRjbLcbLhbLibLibLsbLiLsbLibRsLsRsbRjb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:3;Drug:ControlApo0.5M
bRibRgRiRssbRsbRibLjbRgbLibRibRsRssbLebLibLgbLsbLgbLibLibLibLcbLibLsbRsbLibLgbLgbRgbRcbRjbLibRcbLjLssbRhbRgbLgbLsbRibRjbRibLobLobRibLcbRjbLjbRibLjbLibLobLibRebLjbRobRcbLsbRjbLgbLgbLjbLhbLsbsbRibRibLcLssbLjbLjbRcbLibRjbRibRgbRgbRgbLsbLsbRgbRgbRsbLsbLibLgbRgbLgLebRhbLsbRcb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:4;Drug:ControlApo0.5M
bLcbLiLsbLebLgbLcbRobLcLsLsRsssbRsbLsbRsLsbLebLobLhRsbRsRgbRoRsLssbRgRssbRcb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:5;Drug:ControlApo0.5M
bLjbRhbLsLssbLcbRcbRhLsbRebRoLsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:6;Drug:ControlApo0.5M
bRobLebRobRcbRobLebLjbRsbLcbRsbLob

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:7;Drug:CNO1microMApo0.5M
bLsbRsbsbLsRsLsbRsbRjbLsbRibLhbRebRsbRgbRgbRsbRcbRcRssbReRssbRibRibLibRcbLibRibRhbRebRjbRsbRibRjRssbLhb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:8;Drug:CNO1microMApo0.5M
bRgbLiRsRssbRjbLcRsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:9;Drug:CNO1microMApo0.5M
bRcbRobLibLgbRcbLibLibRhbLib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:10;Drug:CNO1microMApo0.5M
bRobLiRsRssbRobLgbRsbRsbRsbLsbRjbLsbRebRobRsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:11;Drug:CNO1microMApo0.5M
bLibLibLoLssbRjbLibLjbLibRobRjbLcbRjbRgRgbLhbLgb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:12;Drug:CNO1microMApo0.5M
bRcRssbRhbRgbRjbRibRobRiLsbRgb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:13;Drug:CNO3microMApo0.5M
bLjLssbRibRibLgbLjLssbRjRssbLibRsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:14;Drug:CNO3microMApo0.5M
bRcbLcbRgbLgbLobRoRsRsssbLibRsbLhbLibRibLsLssbLcbLcbRibRibLgLsbRjbRsRoRssbLebLsbLibLgbRiLsbLibLgbLgRsbLgbRgbRgbRjbRibRsbLiRsbLobLibLibRjRssb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:15;Drug:CNO3microMApo0.5M
bLcbRobRibLcbRibLibLibLcbLjbLibLjbLibLjbLcbLjbLjbLibLjbLibRgbRibLjbLhRsbLjRsRssbRsRjRssbRibLibLgLsbLgbLjbLjbLibLgbRgbLiLsbRibLibLjbRibLsbRsbLsbRibRibLjRsbLjb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:16;Drug:CNO3microMApo0.5M
bLibLgLsbRcbLcbRcbLcbRibLgbLgRsbRjbRobRobRibRibRgbRiRssbLjLsLsssbLsLibLib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:17;Drug:CNO3microMApo0.5M
bLsbLsbsbLsbLobLsbRoLsbRcbRobRgbRcbRibLsbLsbLsbLgbLibRcbRjbRgbRibRibLibRgb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:18;Drug:CNO3microMApo0.5M
bRgbLjbLsbLsLssbLgbRobLiLsbLsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:19;Drug:CNO10microMApo0.5M
bRsRsRsssbRgbLobRibRsbRibRgbLgbLjbRibRsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:20;Drug:CNO10microMApo0.5M
bLgbLsbRjRsRsRssssbRjbLibLib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:21;Drug:CNO10microMApo0.5M
bLsbLgbRebLcb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:22;Drug:CNO10microMApo0.5M
bLjbRjbRgbRsbRsbLjLssbRjbRsbLjbRib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:23;Drug:CNO10microMApo0.5M
bRebRcRssbRgbRgbRebLgLsbRiRssbsbRibRcbRibRibRgbRgbRgbRsbRhbRgbRoRssbRjbRobRhbRib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:24;Drug:CNO10microMApo0.5M
bLjbRjbLebRjbLiLsbRjbLcLssbLsbRobLoRsRssbRgRssbLgbLsLssbRiRssbRgbRjbRgbLsRsbsbLsbLsLsLsssbRgbLsbRsbLsLssbLcRsLjbRjbRsRib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:25;Drug:ControlApo0.5M
bLibRgbRsbLsLssbLcbLcbLhbLibLcRsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:26;Drug:ControlApo0.5M
bLjbLobLsLobLjbsbsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:27;Drug:ControlApo0.5M
bRjbRoRssbRcbRibRhbRsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:28;Drug:ControlApo0.5M
bsbsbLsLssbsbsbsbRsbsbRsbRgbLsRibRobLgbLhRsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:29;Drug:ControlApo0.5M
bsbRobLib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:30;Drug:ControlApo0.5M
bLsbRsRssbLgbLjbRcbLgbRhbLhbLgLsbLsbLibLgbLgbLgbRsbLibLjbRjbRhb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:31;Drug:CNO1microMApo0.5M
bLjbRgRiRibLjLssbRcb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:32;Drug:CNO1microMApo0.5M
bLgbRjLsbLgbLsbLibLsbLcbRjb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:33;Drug:CNO1microMApo0.5M
bLjbLoRsbRib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:34;Drug:CNO1microMApo0.5M
bLiRsLsbRibRgbRcbRsbLcbLhRsbRib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:35;Drug:CNO1microMApo0.5M
bsbRsbLib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:36;Drug:CNO1microMApo0.5M
bRobRsbLobLsbLgbRebLsbLcbLobRobRsbRebRjbLobLcbLob

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:37;Drug:CNO3microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:38;Drug:CNO3microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:39;Drug:CNO3microMApo0.5M
bLsbRhbRjRgbRcbRsRsRsssbLobLib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:40;Drug:CNO3microMApo0.5M
bRjbRcbRgbLsbLcbLgbRgbLsbLsbRgbRibRgLsbLsbLobRjbRibLjbLhbRjbRibLgbRibRhbRsbLobLcRsbRgbRibRobLjbLhbLgbRsRssbRsRssbRgbLgbRgbRibLibLsbLjLsLiLggbLgbLgbRsbLgbRsbLgbLgLsbLgbRsbLgbLgbLgbLgbLgbLsbLsbLsbLjbLjLibLsRsbRcbLibRsLsbLsbRcbRjbLiLsbLsbLsbLsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:41;Drug:CNO3microMApo0.5M
bRcbLjRsbRoRssbRhbRjbRib

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:42;Drug:CNO3microMApo0.5M
bRjbLcbLjbRobLibRsRcbLgb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:43;Drug:CNO10microMApo0.5M
bRcbLgRsb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:44;Drug:CNO10microMApo0.5M
bLcbLjbLgbLsLssbLsbRsbLsbLgbRsbRsbLsbRibRobRsbRcb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:45;Drug:CNO10microMApo0.5M
bLibLgbLgbLibRiRssbLhbLibLhbLcbLcbRibLibLhbLhbLibLibLibLibLgbRcbLibLgbRibRcbRjbLcbRibRsRssbRibLiRsbRibLibLcLssbLibLgbLsbLgbLgbLsbLgbLgbRsRssbRcbRcbRsbLsbLsbLsbLhbRsbRsbLibLgbLsbLgbLsbLgbLcb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:46;Drug:CNO10microMApo0.5M
bRob

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:47;Drug:CNO10microMApo0.5M
bRsRssbLibRsbRcbLobRibRsbRibRsbRcb

>ZFRecording2016-03-21;tW:300s;Start:141243;End:141743;Recording:12-1;Individual:48;Drug:CNO10microMApo0.5M
bLgbRjbRgbLoLsLsssbRcbRib

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:1;Drug:ControlApo0.5M
bLsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:2;Drug:ControlApo0.5M
bRjbLibRsRsRsRssssbLiLsbLjb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:3;Drug:ControlApo0.5M
bLhbRgRssbRcbLibRcRssbLibLsbLebLebRobRcbRgbRgRibRgLsbRgbRobLgbLibLgbLsRsbLibLobLhbRsRjbRcbRobLibLgbLsbRgbRsbRgbRsbLgbRjbLjbRjbLcbRobRebRcbLibLgbLgbRibRibLgbLjbRibLjbRibLjbLhbLcbRjbRebLibLibLgbLsbLgbLjbRcbLebRibLibRibLjbRjbLjbRjbLjbRcbLibRibLjbRibLsbRibRsbRsbRebRcbLsbLobRebLgbLhLsbLibLgbLgbRjbRgbLjbRibRsbLgbLsbLhbLebRcbLebRebRcLsbRsbLcbLhbLibLgb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:4;Drug:ControlApo0.5M
bRibLsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:5;Drug:ControlApo0.5M
bRcbLobLobRgbRibLsbRgbRgRssbLibRibRgbRjbRobLibRibRsRjbRcbLjbRjb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:6;Drug:ControlApo0.5M
bRobLebLcbLebLgbRsbRsbRsbRsbLjbRebRsbLcbRebRcbRebRebRebRgbRgbRsbRgbRsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:7;Drug:CNO1microMApo0.5M
bRebRsbRsbLsbRsbRebRgbLebRgbLsbRebLgbLoRsbRhbLhbLebRsbRobRsbLebRsbLibRobLsbLjbRsbRjbLsbLsbRebReb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:8;Drug:CNO1microMApo0.5M
b

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:9;Drug:CNO1microMApo0.5M
bRcbLcbRjLsbRgbRibLcb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:10;Drug:CNO1microMApo0.5M
bRibLcbLcbRgbRgbLobLobRiLsRsbRoLsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:11;Drug:CNO1microMApo0.5M
bLibLgbLjb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:12;Drug:CNO1microMApo0.5M
bRsbRgRssbRsbRsbRibRcbLjb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:13;Drug:CNO3microMApo0.5M
bRsbLjbsbRsRssb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:14;Drug:CNO3microMApo0.5M
bLibRibRgbsbRjbRjRssbLibLsbRjb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:15;Drug:CNO3microMApo0.5M
bLjbLcbRgbRsLsbRgbRsLibRhbRcbRhbLjbLcbRcb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:16;Drug:CNO3microMApo0.5M
bRhRssbReRssbLcbLgbRebRhRsRsssbRgbRgbRgbLsbRsbRgRssbRgbRgbRgbRsbRsbRgbRsRssbRsbRgLsbRsbRsRssbRsRssbRgbRgbRgbRobRcbRhbRibRsbRsbRgbRsRssbRhLsbRsbRjRssbRcbRcbRhbRibRibRsbRibRcbRibLibRsbRcbRcbRibRgbRibLjbLebLcbRcbRibRibRhbRibRhbLgbLibRsbRibRsbRgbRgbRgbLsbRsRssbRgbRsbRsbLgbRobRhbRibRcbLebLibRjbRjbRcbRsbRjRsLssbRibLsbLgbLsbLibRsbLsbLsbLjbRjbRcbRcbRhbRgbRgbRgbRibLcbLcbRjbRhbLsbRibRibLgbLibLibRjbLibLgbLhbRjRssbLcbLcbRcbRjbLjbLjLssbLcLssbLhbLhbLgbLsLsRssbLjLssbRsLsLssbLsbRjbLjbRcbLjb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:17;Drug:CNO3microMApo0.5M
bLgbRjbLcbRibLsbLibLibLibRsbLgbRibRcbLibLgbRob

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:18;Drug:CNO3microMApo0.5M
bRsRobRiLsbRhLsbLjRsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:19;Drug:CNO10microMApo0.5M
bsbsbLjbRcbRcbRjbRcbRgbRgbRjbLjb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:20;Drug:CNO10microMApo0.5M
bRsbLsbLgbLcbLjbLcbRobRhbRsLcbLcbLhbLsLssbLebLcLssbLcbLiRsbLibLsbLsbLib

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:21;Drug:CNO10microMApo0.5M
bRsbRobsbLsbRcbRibRgbRsbRhb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:22;Drug:CNO10microMApo0.5M
bRjbLib

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:23;Drug:CNO10microMApo0.5M
bRobRcbLhbLjbLibLobLibLhbRiRssbRgbRcbRibRibLcbLebLib

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:24;Drug:CNO10microMApo0.5M
bLjbRibLsbLcbLoLssbRsbRgbLsbsbsbLjbLjbLobLiRsbRsbRsbsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:25;Drug:ControlApo0.5M
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbsbsbsbLsbsbsbsbRsbsbsbLsbsbRsbLsbsbLsLssbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsRssbLobLsbRgbLgbRsbLsLssbLsbLoRsbRoLsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:26;Drug:ControlApo0.5M
bLebRibLgLgbLgbRsRssbLibRsbLobRjbRhbRjbRebRgbRcbRgbRsRjbRibRhbRibRsbRjbRjbRhbRcbLsbRiRibRcbRhRssbRiRssbRsbRhbLjbRebRibRebRjbReRssbRibRgbRcbLobLibLgbRjbRcLsbRcbRhbsbLibRebLibRibLsbRibLhbRjbLjbLgLsbLsbRsbReb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:27;Drug:ControlApo0.5M
bRsRsLssbRsbLiLsbLobsbLsbRgbRsRssbRsbRgbRjRssbLsbLgbLhbRcbLjbLhRsbLhbLgbRgbRgLsbRibRsLibLoLssbLibLgbLgbRsbRsbRjbLhbRibLsbRibRsbRgbRcbLgbRobRiLsbRcbLgbRibRcbRcbLsbRgbRsbRsbRsbRsbLgbLgbRcbRgbRibRibRibRcbLgbLgbsbLsbLgbRsRssbRgbRgbRibRibLgbRgbRsbRcbRgbLgRsbLgbRibRgbRgbLgbLgbLibLgLsbRcbRibLjbRibLgbRgbRibLibLgbLibLgbLgbRsbLibRsbRcbRjbLjbRjRssbLgbLibRibRjbLibRjb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:28;Drug:ControlApo0.5M
bLgbLibRibLgLsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:29;Drug:ControlApo0.5M
bRgbRibRcbLjbLsbRebLgbLsbLgbRsbLsbRsbLgbLsbLgbRsbRsbRgbLgbRsRssbsbLibLsbLgbLgbRsbRsbRsbRsbLsbLibLgbsbLgbLgbLibLjbLgbLjbLjbRibLibRibLsbRcbLsLibLebLiRsbLjb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:30;Drug:ControlApo0.5M
bRjbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbRsbsbsbRsbsbsbsbsbRsbRsbsbsbsbRsbsbRsbLsLssbRsbLsbsbLsbRsbsbRsbRsRssbRsbRsLsbsbRsbLsbLsbsbLsbsbsbsbLsbLsRsbLsbRsbRsbRsbLsLssbLcbLibLibLibLsbLob

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:31;Drug:CNO1microMApo0.5M
bRsbRcb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:32;Drug:CNO1microMApo0.5M
bsbRjbLgLsbRgbRsbRcbLcb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:33;Drug:CNO1microMApo0.5M
bRobLcbRhbRobRjbRhbRibRgbLjbLsbRsbLebLibLjLssbLibLgbLibRsbLcLssbLhbLjbLgbLgbLgbLsbLgbRsRsRsssbLgbLsbsbLobRibLhbLjbLhbRjbRcbRhb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:34;Drug:CNO1microMApo0.5M
bsbLgb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:35;Drug:CNO1microMApo0.5M
bLsLgbLiLsRsbLibRsbLibRgbLsbLsbLcbLcbRgbRgbRsbRgbRgbRgb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:36;Drug:CNO1microMApo0.5M
bLibLsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:37;Drug:CNO3microMApo0.5M
bRebLobRjbRcbRobLebRebRobRjbRobRjbLsbRebRsbLobLebLobRcbLobLgbRebLobLebLcbLjbRcbLobLobLobRobRjbRjbLjbRobLobRsbRebLobLobLebRobLobLebLobLcbRgbLebLobLjbLobLobRobLebLobLjbLjbRibRcbLobLebLobRjbRjbLcbLjbLobRobLobLobRebLobLobLobLobLobLjbRobLobLcbLhbLobRebLebLobRobLobLobLobLobRibRobRhbLobRobLobLobRebRebRjbLsbLebRobLobLobLcbRebLobLebLcbLebRjbLobRobRsbLobLobRjbLjbRebLebLebLsbLhbRobRjbLjbRcbRobLobRobLebRobLcbLobLjbRebRobRebLebLcbRobLobRjbRcbLjbLebRebRobLobRebLebLsbRebLjbRjbLcbRobRobRobLobRebLobRobLjbLjbLobLjbRobLjbLcbLcbLobLcbRobRgbLobLebLobRebLobLebLobRobLcbLobLjbLobRcbRsbRhbLobRcbRjbRcbRjbLobLebRjbLebRobLsbRobRobLebRobLebRebRobLobLgbRjbLsbLjbLsbRobRebLobRobRobLebLhbLobLjbLebRobLobLobLgbLgbLobLibRcbLobRebLobRobLobLobLobLobRebLobRcbRobRobRebRibRcbRebRebLgbRebLobLobLobRebRibLjbLebRebRcbLgbLcbRobRobRobLcbRebLobRobRebLebRobRibRobLcbLobLsbRcbLebRebRobRcbRobRebRcbRobLobRjbLjbLebLobLobLobRebRcbLobRobLcbRebRcbRcbLobLgbRjbLebLobRobRjbLcbRobRgbLobLobLebLebLebRobRibLgbLebLcbRobLobLobLobRcbRhbLjbRebRcbRobRobLcbLcbLibRcbRibLobLcbRobRhbRcbLobRibRobRobRobLsbLobRobRobLjbRcbRobRobLsbRjbRsbLibRobRobRebRebRcbRebRjbLcbLobRebLebLobRobLobRobRcbRhbLebLsbLsbLobRibLobLcbLobRobLjbRebRobRobRcbLjbRobRebLhbRjbRcbRebLsbLebRcbRobLibLjbRjbRebRsbLcbLobRsbRobLebLebRcbLjbLobLobRjbRgbLobRibLebRibLcbRjbLebLgbRgbRobLgbLobRcbRobRibRobLobLibRebLibRhbLebLobRobLcbLcbLebLobLcbRobLibLsbLjbLobRobLcbRobRhbRobLobLcbRobRebLibRsbRobLobLobLobLjbRjbRobRjbRibLgbLebRobRhbRobLibLobLibRobRebLjbLebRobRobRobRcbLobRobLjbRobRjbRobRebLibRobRobLobRjbRobLobRobLobLjbLjbLobLcbRsbRobLebRjbLcbLebLjbLobRjbLobLebLebLobLsbRobLobLobLcbLebRobLobRobRibLobLobLcbRebLobLgbRebRcbLobRcbRobRjbRebRobLcbLebLobLjbRcbRebRgbRcbRjbRcbRebLebRobRebLjbLobLgbLobRgbRjbLcbRibRsbLcbRcbRcbRobLebLcbRcbLcbRcbRobLebLcbLobRcbLebLobLjbLebLobLobLobRobLobLibRobLsbRcbRobLcbRjbLobRgbRjbRcbLobLibLobLobRobLobRcbRobRcbRjbLebRjbRebRcbLebLebLobRobLobLobRcbLebRobLobRobLobRjbLcbRjbLjbLebLibRobRcbLobRobLibRebLobRobRcbLjbRgbRobRobRcbRobRobLobRebLobRjbRibRobRebRebLebRcbRcbRobRjbRobRibRsbLobLobRobLebRobLjbRjbLobRobRsbRsbLobRobLobLobLebRebRobLobRebRsbRebRobRobRcbRjbLjbLobRebLcbRobRebLcbRobRobRjbRcbRobRcbRobLobLebLcbLcbLobLobRcbLebRobRcbLobRobRsbLobRobRobLebLcbLebLobLjbLebRebRebRobLjbLsbRjbLobLsbLobLobLcbRobLobRobRjbLobRcbLobRibRibRgbLebRjbLjbLobLsbLebRobLobLgbRobLobRobLobLebLsbRcbRobRjbLcbLsbRebRobRjbRobLcbRjbRjbRebRobLjbLobLebRobRebRobRobLebLjbRobLgbRjbLebLebLobLobLobRjbRobLobRcbLjbLobRcbRebRjbRcbRjbRobLobLjbRjbLebRebRobRebRcbLsbLcbRobLobLcbLobLobRebRjbLobLobRobRcbLobRcbRobLobLcbRjbRebRobRebRhbRsbRobLsbRsbRobRobLcbLjbRcbLobRjbLcbLsbRobLobLobLobLjbRsbRobLjbRebLobRjbRebLcbLebRobLobRcbLobLobLjbRcbRobRibLsbLobRebLjbLobLobLsbLcbLjbRgbRcbRobRobLcbLjbLcbLobRcbRjbRebLjbLcbRibRobRobLobRobLjbLobRsbLjbLebRobRebLjbLcbLsbRebLobLobRobRjbLsbLcbRcbRsbRjbRcbRebLsbLjbRobLebLobRjbLcbLebRjbRobRebRobRobLebRobRebRebRebRobLsbRjbRjbLebLjbRobRjbLobRjbLebRobRebLobRebLcbLobLcbRebRobRebLjbLobRjbRobLgbRsbRebLebRobRobLebRcbRobRsbRcbLcbRebLobLjbLcbRobLobRobRjbRobRobRobLobLobLebLobRebRjbLjbRebLebLobLcbLgbLjbRjbLcbLeb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:38;Drug:CNO3microMApo0.5M
bRsbLhbLgRjb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:39;Drug:CNO3microMApo0.5M
bRiLsbLsRsbLhbLhbRcb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:40;Drug:CNO3microMApo0.5M
bRjRssbLjbRcbLibLsbLsbLsbLsbRsbRgbRjb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:41;Drug:CNO3microMApo0.5M
bRoRssbRibRobLobRcb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:42;Drug:CNO3microMApo0.5M
bRjRssbRsRsRsssbRebLcbsbLcbRoLsLssbRibLjbLhLsRsbRsbLibLibLcbRhbRobRebLgbLobLgbLibLobLibLgbLebLiRsbRsbLgbLgbLgLsbLsbRsLsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:43;Drug:CNO10microMApo0.5M
bRobRsRgbRgbRobLibRhbLibRhRssbRibLjbLhbLgLsbLsbLsbRobLsRsbLcbLgbRcRjbLcLssb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:44;Drug:CNO10microMApo0.5M
bRsbRsRsRsssbLsbRsbLsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:45;Drug:CNO10microMApo0.5M
bRgbLgbLibLgbLgbRibLcbLsbLibLgbLsbLibLibLsbLgbLgbLibLiRsbRibLgbLsRsbLibRibLhbLibLibLibRjLsbLjRsbLibLcbRsbRibLsbLcbLibLibRiLsbRsbLgbLgbLgbLsbLcbRiRssbRsbRsbLjbLibRsLsbLgbLgbLsbLsbLgbLgbRcbLcbLgbLibLsbLsbLsbLiRsRssbRsbsbLsbLgbLsbLgbLgbRjbRibRcbRgbRibRsbRibRgbRsbRsbLsbRibLjbLgbLhbRcbLiLsbLgbLgbLsRsbLjbLgbRjRjbLcbLiRsbLiLsbLsbLibLgbLgbLsbLgbLsbLibLgbRsRssbLsbRgbRcbRcbLibLgbLibRhbLcbLibLgbsbRibLibLibLsbLgbLsbLibLsbLiRsbRsbLsLssbLsbLibRgLsbLibLsbLgRsbLsbLibLibRgRssbLibLgbLsbRhRssbLjbLibRjbRcbRibLsRsbRibLgbLgbLsbLsbLgbLgLsbRcLsbRibLjLssbRcbRsbLibRsbLibLgbLiLibLgbRsbLgbLgbLiRsbRibLibLsbLgbRsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:46;Drug:CNO10microMApo0.5M
bLibRjbRcbRgb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:47;Drug:CNO10microMApo0.5M
bLhbLjbRgbRsb

>ZFRecording2016-03-21;tW:300s;Start:141745;End:142245;Recording:13-1;Individual:48;Drug:CNO10microMApo0.5M
bLcRsbRibLjRsbLobRobRibRgbLobRcbRib

